var title_f11_19_11568="Map of East Asia";
var content_f11_19_11568=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Map of East Asia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11568=[""].join("\n");
var outline_f11_19_11568=null;
var title_f11_19_11569="Contents: Fluid and electrolytes";
var content_f11_19_11569=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?0/41/670\">",
"       Nephrology and Hypertension",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Fluid and electrolytes",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Fluid and electrolytes",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Drug effects",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/5/38998\">",
"           Amphotericin B nephrotoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/44/32451\">",
"           Complications of mannitol therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29094\">",
"           Diuretic-induced hyperuricemia and gout",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/39/19061\">",
"           Diuretics and calcium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/41/43668\">",
"           Diuretics and magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14806\">",
"           Ifosfamide nephrotoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40710\">",
"           Loop diuretics: Maximum effective dose and major side effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39128\">",
"           Mechanism of action of diuretics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/43/42674\">",
"           NSAIDs and acetaminophen: Effects on blood pressure and hypertension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/57/38803\">",
"           NSAIDs: Electrolyte complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/14/32999\">",
"           Renal toxicity of lithium",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/45/6868\">",
"           Time course of loop and thiazide diuretic-induced electrolyte complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/55/3962\">",
"           Use of diuretics in patients with heart failure",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Edematous states",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/36/34375\">",
"           Clinical manifestations and diagnosis of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/50/30503\">",
"           General principles of the treatment of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/12/17608\">",
"           Hyponatremia in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/53/38742\">",
"           Hyponatremia in patients with heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/31/20981\">",
"           Idiopathic edema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/44/19145\">",
"           Initial therapy of ascites in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39128\">",
"           Mechanism of action of diuretics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/22/19818\">",
"           Natriuretic peptide measurement in heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21527\">",
"           Pathogenesis of ascites in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/34/36393\">",
"           Pathophysiology and etiology of edema in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/40/35465\">",
"           Treatment of diuretic-resistant ascites in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/40/650\">",
"           Treatment of refractory edema in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/46/28391\">",
"           Adrenal steroid biosynthesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40838\">",
"           Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/32/15878\">",
"           Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/44/9930\">",
"           Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22615\">",
"           Familial hyperaldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/51/35641\">",
"           Uncommon causes of congenital adrenal hyperplasia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypercalcemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/28/20934\">",
"           Diagnostic approach to hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19258\">",
"           Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/22/28007\">",
"           Etiology of hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/42/16041\">",
"           Treatment of hypercalcemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperkalemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/5/33882\">",
"           Causes and evaluation of hyperkalemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/2/44069\">",
"           Clinical manifestations of hyperkalemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/44/9930\">",
"           Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/17/25876\">",
"           Hyponatremia and hyperkalemia in adrenal insufficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/18/25891\">",
"           Potassium balance in acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10069\">",
"           Renal effects of ACE inhibitors in heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/54/17258\">",
"           Treatment and prevention of hyperkalemia in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypermagnesemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/58/13220\">",
"           Causes and treatment of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/9/32914\">",
"           Symptoms of hypermagnesemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypernatremia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/63/36857\">",
"           Etiology and evaluation of hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/48/11018\">",
"           General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/58/23464\">",
"           Manifestations of hyponatremia and hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/52/24393\">",
"           Treatment of hypernatremia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperphosphatemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/13/13527\">",
"           Overview of the causes and treatment of hyperphosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/57/33690\">",
"           Treatment of hyperphosphatemia in chronic kidney disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypocalcemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/13/34005\">",
"           Diagnostic approach to hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19258\">",
"           Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/25/24984\">",
"           Etiology of hypocalcemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/37/44632\">",
"           Treatment of hypocalcemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypokalemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40838\">",
"           Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/43/23226\">",
"           Bartter and Gitelman syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/17/5402\">",
"           Causes of hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/2/9258\">",
"           Clinical manifestations and treatment of hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/9/9366\">",
"           Evaluation of the patient with hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22615\">",
"           Familial hyperaldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/51/25399\">",
"           Genetic disorders of the collecting tubule sodium channel: Liddle's syndrome and pseudohypoaldosteronism type 1",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/54/871\">",
"           Hyperkalemic periodic paralysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/6/6245\">",
"           Hypokalemia-induced renal dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/62/9193\">",
"           Hypokalemic periodic paralysis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/18/25891\">",
"           Potassium balance in acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypomagnesemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/41/15000\">",
"           Causes of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/63/11254\">",
"           Evaluation and treatment of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16085\">",
"           Significance of hypomagnesemia in cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/37/42580\">",
"           Signs and symptoms of magnesium depletion",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyponatremia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/30/3562\">",
"           Causes of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/23/8567\">",
"           Cerebral salt-wasting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/31/502\">",
"           Diuretic-induced hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/23/38260\">",
"           Estimation of the sodium deficit in patients with hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/20/21832\">",
"           Evaluation of the patient with hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/42/1706\">",
"           Exercise-associated hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/17/25876\">",
"           Hyponatremia and hyperkalemia in adrenal insufficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/41/8858\">",
"           Hyponatremia following transurethral resection or hysteroscopy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/12/17608\">",
"           Hyponatremia in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/53/38742\">",
"           Hyponatremia in patients with heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/58/23464\">",
"           Manifestations of hyponatremia and hypernatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10074\">",
"           Osmotic demyelination syndrome and overly rapid correction of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/34/18986\">",
"           Overview of the treatment of hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/46/7913\">",
"           Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/57/17306\">",
"           Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypophosphatemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/25/15767\">",
"           Causes of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2167\">",
"           Diagnosis and treatment of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/42/28324\">",
"           Hypophosphatemia in the alcoholic patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14806\">",
"           Ifosfamide nephrotoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/57/32659\">",
"           Signs and symptoms of hypophosphatemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Issues in diabetes mellitus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/16/44295\">",
"           Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/7/34935\">",
"           Maintenance and replacement fluid therapy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metabolic acidosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/57/29589\">",
"           Acid-base and electrolyte abnormalities with diarrhea or ureteral diversion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/29/6613\">",
"           Alcoholic and fasting ketoacidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31432\">",
"           Approach to the adult with metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/44/40646\">",
"           Bicarbonate therapy in lactic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/44/3781\">",
"           Causes of lactic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/18/18723\">",
"           D-Lactic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/16/44295\">",
"           Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/44/18120\">",
"           Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14806\">",
"           Ifosfamide nephrotoxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/3/4154\">",
"           Methanol and ethylene glycol poisoning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/26/23973\">",
"           Nephrolithiasis in renal tubular acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/32/10759\">",
"           Overview of renal tubular acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/24/41353\">",
"           Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/13/19672\">",
"           Pathophysiology of renal tubular acidosis and the effect on potassium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/18/25891\">",
"           Potassium balance in acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/43/36533\">",
"           Serum anion gap in conditions other than metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/61/20437\">",
"           Strong ions and the analysis of acid-base disturbances (Stewart approach)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21526\">",
"           The ������anion gap/������HCO3 ratio in patients with a high anion gap metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5860\">",
"           Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/18/11558\">",
"           Urine anion and osmolal gaps in metabolic acidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metabolic alkalosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40838\">",
"           Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/43/23226\">",
"           Bartter and Gitelman syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/22/8551\">",
"           Causes of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39479\">",
"           Clinical manifestations and evaluation of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/51/25399\">",
"           Genetic disorders of the collecting tubule sodium channel: Liddle's syndrome and pseudohypoaldosteronism type 1",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/28/10692\">",
"           Pathogenesis of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/14/14568\">",
"           Treatment of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/46/28391\">",
"           Adrenal steroid biosynthesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36570\">",
"           Assessment of kidney function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/23/35190\">",
"           Calculation of the creatinine clearance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/57/41875\">",
"           Drugs that elevate the serum creatinine concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39332\">",
"           Electrolyte disturbances with HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/56/24457\">",
"           Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/50/29482\">",
"           Hepatorenal syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/0/7177\">",
"           Hypouricemia: Causes and clinical significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/60/20423\">",
"           Isopropyl alcohol poisoning",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/7/34935\">",
"           Maintenance and replacement fluid therapy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/22/19818\">",
"           Natriuretic peptide measurement in heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/61/24533\">",
"           Nitric oxide and the kidney",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/0/41988\">",
"           Reciprocal serum creatinine concentration and chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/25/44435\">",
"           Renal actions of dopamine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/53/10069\">",
"           Renal effects of ACE inhibitors in heart failure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/29/41430\">",
"           Serum osmolal gap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/20/13639\">",
"           Treatment of severe hypovolemia or hypovolemic shock in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Polyuria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21048\">",
"           Clinical manifestations and causes of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/2/21545\">",
"           Clinical manifestations and causes of nephrogenic diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24312\">",
"           Diagnosis of polyuria and diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/14/32999\">",
"           Renal toxicity of lithium",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/31/505\">",
"           Treatment of central diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/32/24071\">",
"           Treatment of nephrogenic diabetes insipidus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/34/6691\">",
"           Urine output in diabetes insipidus",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-E1AEB1CF96-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f11_19_11569=[""].join("\n");
var outline_f11_19_11569=null;
var title_f11_19_11570="Patient information: Adrenal crisis (The Basics)";
var content_f11_19_11570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83807\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/50/27424\">",
"         Endocrine glands",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?20/26/20898\">",
"         Patient information: Addison&rsquo;s disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/56/19330\">",
"         Patient information: Congenital adrenal hyperplasia (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/0/9220\">",
"         Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Adrenal crisis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/adrenal-crisis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H1671090105\">",
"      <span class=\"h1\">",
"       What is adrenal crisis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Adrenal crisis is a serious medical problem that can cause you to pass out and even lead to death. It happens when your adrenal glands are not working right. The adrenal glands are a pair of organs that are located on top of the kidneys (",
"      <a class=\"graphic graphic_figure graphicRef67279 \" href=\"UTD.htm?26/50/27424\">",
"       figure 1",
"      </a>",
"      ). These glands make a lot of different hormones, including 2 hormones that are very important for normal body function:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Aldosterone &ndash; This hormone helps control the amount of salt and fluid in the body.",
"       </li>",
"       <li>",
"        Cortisol &ndash; This hormone helps control how the body uses sugar and how it responds to stress.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Adrenal crisis happens when the adrenal glands do not release enough of 1 or both of these hormones. If you do not have enough of these hormones, your body can go into shock. That is when your blood pressure drops to a dangerously low level and you pass out. Adrenal crisis is a medical emergency.",
"     </p>",
"     <p>",
"      <strong>",
"       What are the symptoms of adrenal crisis?",
"      </strong>",
"      &ndash; Adrenal crisis usually comes on suddenly. The symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Vomiting",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Weakness",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Confusion",
"       </li>",
"       <li>",
"        Passing out",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090137\">",
"      <span class=\"h1\">",
"       What causes adrenal crisis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Adrenal crisis usually happens in people who already have a medical condition that affects the adrenal glands. For example, it can happen in people who have Addison&rsquo;s disease (also called &ldquo;adrenal insufficiency&rdquo;) or congenital adrenal hyperplasia (also called &ldquo;CAH&rdquo;).",
"     </p>",
"     <p>",
"      People who have these adrenal problems must take hormones to replace the hormones they lack. But if they get sick, get into an accident, or have surgery, the hormones they normally take are not always enough. That&rsquo;s why people with adrenal problems sometimes have to take extra medicine when they are sick or when they know they are going to have surgery.",
"     </p>",
"     <p>",
"      Adrenal crisis can also happen in people who take medicines called steroids at high doses for a long time and suddenly stop taking them. Plus it can happen in people who have bleeding in their adrenal glands because of infection or severe injury, or because they were taking blood thinners.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090152\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, if you have symptoms of adrenal crisis, call 9-1-1 for an ambulance. This is especially important if you already know that you have a medical condition that affects your adrenal glands (such as Addison&rsquo;s disease).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090167\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor or nurse suspects you have adrenal crisis, he or she will order blood tests to check your blood sugar and hormone levels.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090182\">",
"      <span class=\"h1\">",
"       How is adrenal crisis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment is done at the hospital and involves getting 2 things though a tube in a vein (called an IV):",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fluids with salt and sugar to replace what has been lost",
"       </li>",
"       <li>",
"        Hormone medicines to replace the hormones that are missing",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Once doctors have treated the crisis, they will try to find out what caused the crisis in the first place. For example, they will check for infection or for signs of adrenal gland problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090197\">",
"      <span class=\"h1\">",
"       Can adrenal crisis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have a medical condition that keeps your adrenal glands from making enough hormones, your doctor will give you hormone medicines to replace what is missing. These medicines can reduce the chances you will have adrenal crisis again.",
"     </p>",
"     <p>",
"      People usually need to take these medicines every day for the rest of their life.",
"     </p>",
"     <p>",
"      It is important to let your doctor or nurse know if you have any side effects from the medicines or develop any new symptoms.",
"     </p>",
"     <p>",
"      Your doctor might also prescribe emergency medicine that you should keep with you at all times in case you have adrenal crisis again. This medicine comes in the form of a shot. If you think you are having adrenal crisis, use this medicine and then call 9-1-1 for an ambulance.",
"     </p>",
"     <p>",
"      Your doctor might recommend that you also use this emergency medicine if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Get very sick with a high fever",
"       </li>",
"       <li>",
"        Have a major injury, for example if you break a bone or lose a lot of blood",
"       </li>",
"       <li>",
"        Pass out",
"       </li>",
"       <li>",
"        Vomit up your daily medicine",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H1671090212\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/26/20898?source=see_link\">",
"       Patient information: Addison&rsquo;s disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/56/19330?source=see_link\">",
"       Patient information: Congenital adrenal hyperplasia (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=see_link\">",
"       Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/19/11570?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83807 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-0D12DA5E94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11570=[""].join("\n");
var outline_f11_19_11570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090105\">",
"      What is adrenal crisis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090137\">",
"      What causes adrenal crisis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090152\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090167\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090182\">",
"      How is adrenal crisis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090197\">",
"      Can adrenal crisis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1671090212\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83807\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/50/27424\">",
"      Endocrine glands",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/26/20898?source=related_link\">",
"      Patient information: Addison&rsquo;s disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/0/9220?source=related_link\">",
"      Patient information: Adrenal insufficiency (Addison's disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/56/19330?source=related_link\">",
"      Patient information: Congenital adrenal hyperplasia (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_19_11571="Ileal brake";
var content_f11_19_11571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F62927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F62927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Peptide YY and the \"ileal brake\"",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the ileal brake where exposure of the distal ileum to fat and/or unabsorbed nutrients decreases gastric emptying, pancreatic secretion, and bowel motility. This response is mediated, in part, by peptide YY.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Mannon P, Taylor IL. The Pancreatic Polypeptide Family. In: Gut Peptides, Biochemistry and Physiology, Walsh JH, Dockray JG (Eds), Raven Press Ltd, New York 1994. p.341.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11571=[""].join("\n");
var outline_f11_19_11571=null;
var title_f11_19_11572="Cervical dysgenesis";
var content_f11_19_11572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67197&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Congenital cervical dysgenesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 547px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cervical body is intact (A) with obstruction of the cervical os. The cervical body (B) consists of a fibrous band of variable diameter that may contain endocervical glands. Fragmented portions of the cervix are noted (C) with no connection to the uterine body. Hypoplasia of the uterine cavity may be associated with cervical cords or fragmentation. The midportion of the cervix (D) is hypoplastic with a bulbous tip. No cervical lumen is identified.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn with permission from: Rock, JA, Carpenter, SE, Wheeless, CR, Jones, Jr., HW. The clinical management of maldevelopment of the uterine cervix. Journal of Pelvic Surgery 1995; 1:129.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11572=[""].join("\n");
var outline_f11_19_11572=null;
var title_f11_19_11573="Normal placenta";
var content_f11_19_11573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal placenta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11573=[""].join("\n");
var outline_f11_19_11573=null;
var title_f11_19_11574="Benzocaine: Pediatric drug information";
var content_f11_19_11574=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Benzocaine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"    see \"Benzocaine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?26/58/27557?source=see_link\">",
"    see \"Benzocaine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F139882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Americaine&reg; Hemorrhoidal [OTC];",
"     </li>",
"     <li>",
"      Anbesol&reg; Baby [OTC];",
"     </li>",
"     <li>",
"      Anbesol&reg; Cold Sore Therapy [OTC];",
"     </li>",
"     <li>",
"      Anbesol&reg; Jr. [OTC];",
"     </li>",
"     <li>",
"      Anbesol&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Anbesol&reg; [OTC];",
"     </li>",
"     <li>",
"      Benzodent&reg; [OTC];",
"     </li>",
"     <li>",
"      Bi-Zets [OTC];",
"     </li>",
"     <li>",
"      Boil-Ease&reg; Pain Relieving [OTC];",
"     </li>",
"     <li>",
"      Cepacol&reg; Fizzlers&trade; [OTC];",
"     </li>",
"     <li>",
"      Cepacol&reg; Sore Throat &amp; Coating [OTC];",
"     </li>",
"     <li>",
"      Cepacol&reg; Sore Throat Plus Coating Relief [OTC];",
"     </li>",
"     <li>",
"      Cepacol&reg; Sore Throat [OTC];",
"     </li>",
"     <li>",
"      Cepacol&reg; Ultra Sore Throat [OTC];",
"     </li>",
"     <li>",
"      Chiggerex&reg; Plus [OTC];",
"     </li>",
"     <li>",
"      ChiggerTox&reg; [OTC];",
"     </li>",
"     <li>",
"      Dent's Extra Strength Toothache Gum [OTC];",
"     </li>",
"     <li>",
"      Dentapaine [OTC];",
"     </li>",
"     <li>",
"      Dermoplast&reg; Antibacterial [OTC];",
"     </li>",
"     <li>",
"      Dermoplast&reg; Pain Relieving [OTC];",
"     </li>",
"     <li>",
"      Detane&reg; [OTC];",
"     </li>",
"     <li>",
"      Foille&reg; [OTC];",
"     </li>",
"     <li>",
"      HDA&reg; Toothache [OTC];",
"     </li>",
"     <li>",
"      HurriCaine ONE&trade;;",
"     </li>",
"     <li>",
"      Hurricaine&reg; [OTC];",
"     </li>",
"     <li>",
"      Ivy-Rid&reg; [OTC];",
"     </li>",
"     <li>",
"      Kank-A&reg; Soft Brush [OTC];",
"     </li>",
"     <li>",
"      Lanacane&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Lanacane&reg; [OTC];",
"     </li>",
"     <li>",
"      Little Teethers&reg; [OTC];",
"     </li>",
"     <li>",
"      Medicone&reg; Hemorrhoidal [OTC];",
"     </li>",
"     <li>",
"      Mycinettes&reg; [OTC];",
"     </li>",
"     <li>",
"      Orabase&reg; with Benzocaine [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Baby Daytime and Nighttime [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Baby Teething Nighttime [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Baby Teething [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Cold Sore [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Denture Plus [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Medicated Mouth Sore [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Medicated Toothache [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Mouth Sore [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Multi-Action Cold Sore [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; PM Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; Ultra Mouth Sore [OTC];",
"     </li>",
"     <li>",
"      Orajel&reg; [OTC];",
"     </li>",
"     <li>",
"      Outgro&reg; [OTC];",
"     </li>",
"     <li>",
"      Red Cross&trade; Canker Sore [OTC];",
"     </li>",
"     <li>",
"      Rid-A-Pain Dental [OTC];",
"     </li>",
"     <li>",
"      Sepasoothe&reg; [OTC];",
"     </li>",
"     <li>",
"      Skeeter Stik&reg; [OTC];",
"     </li>",
"     <li>",
"      Sore Throat Relief [OTC];",
"     </li>",
"     <li>",
"      Sting-Kill&reg; [OTC];",
"     </li>",
"     <li>",
"      Tanac&reg; [OTC];",
"     </li>",
"     <li>",
"      Thorets [OTC];",
"     </li>",
"     <li>",
"      Trocaine&reg; [OTC];",
"     </li>",
"     <li>",
"      Zilactin&reg; Tooth &amp; Gum Pain [OTC];",
"     </li>",
"     <li>",
"      Zilactin&reg;-B [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F139883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Anbesol&reg; Baby;",
"     </li>",
"     <li>",
"      Zilactin Baby&reg;;",
"     </li>",
"     <li>",
"      Zilactin-B&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Oral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Topical",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"      see \"Benzocaine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mucous membranes: Dosage varies depending on area to be anesthetized and vascularity of tissues",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral mouth/throat preparations: Do not administer for &gt;2 days or in children &lt;2 years of age, unless directed by a physician; refer to specific package labeling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: 4-5 drops into ear canal; may repeat every 1-2 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical: Apply to affected area as needed",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F139869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, spray, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (60 mL) [dye free; wild cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, spray, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermoplast&reg; Antibacterial: 20% (82.5 mL) [contains aloe, benzethonium chloride, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermoplast&reg; Pain Relieving: 20% (60 mL, 82.5 mL) [contains menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ivy-Rid&reg;: 2% (85 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lanacane&reg; Maximum Strength: 20% (120 mL) [contains ethanol 36%]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Combination package, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Baby Daytime and Nighttime: gel, oral (Daytime Regular formula): benzocaine 7.5% (5.3 g) [1 tube] and gel, oral (Nighttime formula): benzocaine 10% (5.3 g) [1 tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Benzodent&reg;: 20% (7.5 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; PM Maximum Strength: 20% (5.3 g, 7 g) [contains menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lanacane&reg;: 6% (28 g, 60 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lanacane&reg; Maximum Strength: 20% (28 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, oral: 20% (15 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg;: 10% (7.1 g) [contains benzyl alcohol; cool mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg; Baby: 7.5% (7.1 g) [contains benzoic acid; grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg; Jr.: 10% (7.1 g) [contains benzyl alcohol; bubblegum flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg; Maximum Strength: 20% (7.1 g, 10 g) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dentapaine: 20% (11 g) [contains clove oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HDA&reg; Toothache: 6.5% (15 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (30 g) [dye free; fresh mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (30 g) [dye free; pina colada flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (30 g) [dye free; watermelon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (5.25 g, 30 g) [dye free; wild cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kank-A&reg; Soft Brush: 20% (2 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Little Teethers&reg;: 7.5% (9.4 g) [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orabase&reg; with Benzocaine: 20% (7 g) [contains ethanol 48%; fresh mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg;: 10% (5.3 g, 7 g, 9.4 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Baby Teething: 7.5% (11.9 g); 7.5% (9.4 g) [cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Baby Teething Nighttime: 10% (5.3 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Denture Plus: 15% (9 g) [contains ethanol 66.7%, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Maximum Strength: 20% (5.4 g, 7 g, 9.4 g, 11.9 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Mouth Sore: 20% (5.3 g, 9.4 g, 11.9 g) [contains allantoin, benzalkonium chloride, zinc chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Multi-Action Cold Sore: 20% (9.4 g) [contains allantoin, camphor, dimethicone]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Ultra Mouth Sore: 15% (9.4 g) [contains ethanol 66.7%, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zilactin&reg;-B: 10% (7.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Detane&reg;: 7.5% (15 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral: 20% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg;: 10% (9.3 mL) [contains benzyl alcohol; cool mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg; Maximum Strength: 20% (9.3 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (30 mL) [dye free; pina colada flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Baby Teething: 7.5% (13.3 mL) [very berry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Maximum Strength: 20% (13.5 mL) [contains ethanol 44.2%, tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tanac&reg;: 10% (13 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rid-A-Pain Dental: 6.3% (30 mL) [contains ethanol 70%]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Ultra Sore Throat: 5% (22.2 mL) [sugar free; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HurriCaine ONE&trade;: 20% (0.5 mL) [wild cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ChiggerTox&reg;: 2% (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Outgro&reg;: 20% (9.3 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Skeeter Stik&reg;: 5% (14 mL) [contains isopropyl alcohol, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lozenge, oral: 6 mg (18s [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bi-Zets: 15 mg (10s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Sore Throat: 15 mg (16s) [contains cetylpyridinium, menthol; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Sore Throat: 15 mg (16s) [contains cetylpyridinium, menthol; honey-lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Sore Throat: 15 mg (16s) [sugar free; contains cetylpyridinium, menthol; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Sore Throat &amp; Coating: 15 mg (16s) [sugar free; contains cetylpyridinium, pectin; lemon-lime flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Sore Throat Plus Coating Relief: 15 mg (18s) [sugar free; contains cetylpyridinium, pectin; lemon-lime flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mycinettes&reg;: 15 mg (12s) [sugar free; contains sodium 9 mg/lozenge; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mycinettes&reg;: 15 mg (12s) [sugar free; contains sodium 9 mg/lozenge; regular flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sepasoothe&reg;: 10 mg (6s, 24s, 100s, 250s, 500s) [sugar free; contains cetylpyridinium 0.5 mg/lozenge; wild cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sore Throat Relief: 10 mg (100s, 250s, 500s) [sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thorets: 18 mg (300s) [sugar free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Trocaine&reg;: 10 mg (50s, 300s) [cherry-menthol flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Anbesol&reg; Cold Sore Therapy: 20% (7.1 g) [contains allantoin, aloe, benzyl alcohol, camphor, menthol, vitamin E]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Red Cross&trade; Canker Sore: 20% (7.5 g) [contains coconut oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Americaine&reg; Hemorrhoidal: 20% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Medicone&reg; Hemorrhoidal: 20% (28.4 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Boil-Ease&reg; Pain Relieving: 20% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chiggerex&reg; Plus: 6% (50 g) [contains aloe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Foille&reg;: 5% (3.5 g, 14 g, 28 g) [contains benzyl alcohol, chloroxylenol, corn oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Pad, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sting-Kill&reg;: 20% (8s) [contains menthol, tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Paste, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orabase&reg; with Benzocaine: 20% (6 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Swab, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hurricaine&reg;: 20% (8s, 72s) [dye free; wild cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Baby Teething: 7.5% (12s) [berry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Cold Sore: 20% (12s) [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Medicated Mouth Sore: 20% (8s, 12s) [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Orajel&reg; Medicated Toothache: 20% (8s, 12s) [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zilactin&reg; Tooth &amp; Gum Pain: 20% (8s) [grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Swab, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Boil-Ease&reg; Pain Relieving: 20% (12s) [contains tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sting-Kill&reg;: 20% (5s) [contains menthol, tartrazine]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, orally dissolving, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cepacol&reg; Fizzlers&trade;: 6 mg (12s) [grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Wax, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dent's Extra Strength Toothache Gum: 20% (1 g)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F139856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Lozenge, liquid",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mucous membranes: Apply to mucous membrane; do not eat for 1 hour after application to oral mucosa",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: After instilling into external ear canal, insert cotton pledget into ear canal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical: Apply evenly; do not apply to deep or puncture wounds or to serious burns",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F4627697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Temporary relief of pain associated with pruritic dermatosis, pruritus, minor burns, toothache, minor sore throat pain, canker sores, hemorrhoids, rectal fissures; anesthetic lubricant for passage of catheters and endoscopic tubes",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F139920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Orabase&reg;  may be confused with Orinase",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F139918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Methemoglobinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning, contact dermatitis, edema, erythema, pruritus, rash, stinging, tenderness, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to benzocaine, other ester-type local anesthetics, or any component; secondary bacterial infection of area; perforated tympanic membrane (otic formulations only)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1056767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Benzocaine gels, liquids, and sprays used in the mouth, throat, and other mucous membranes have been associated with an increased risk for developing methemoglobinemia; methemoglobinemia is a serious and potentially fatal condition in which the amount of oxygen carried through the blood stream is greatly reduced; signs and symptoms may include pale-, gray-, or blue-colored skin, lips, and nail beds; headache; lightheadedness; shortness of breath; fatigue; and rapid heart rate and have been reported to appear within minutes to hours of applying benzocaine and may occur with the first application or prolonged use. The majority of cases associated with benzocaine use have been in infants and children &lt;2 years of age for treatment of teething pain; also at greater risk for development are patients with asthma, bronchitis, emphysema, mucosal damage, or inflammation at the application site, heart disease, and malnutrition. The classical clinical finding of methemoglobinemia is chocolate brown-colored arterial blood; however, suspected cases should be confirmed by co-oximetry, which yields a direct and accurate measure of methemoglobin levels (standard pulse oximetry readings or arterial blood gas values are not reliable). The FDA recommends avoidance of self-treatment of OTC products for teething pain in infants and children &lt;2 years of age; use cautiously in other patients or select another product. Clinically significant methemoglobinemia requires immediate treatment. Patients with a greater tendency for elevated levels of methemoglobin, eg, G-6-PD deficiency, hemoglobin-M disease, NADH-methemoglobin reductase deficiency, and pyruvate-kinase deficiency may benefit from products with an alternative anesthetic (eg, lidocaine).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Topical use prior to cosmetic procedures can result in high systemic levels and lead to toxic effects (eg arrhythmias, seizures, coma, respiratory depression, and death), particularly when applied in large amounts to cover large areas and/or left on for long periods of time or used with materials, wraps, or dressings to cover the skin after anesthetic application. These practices may increase the degree of systemic absorption and should be avoided. The FDA is recommending consumers consult their healthcare provider for instructions on safe use prior to applying topical anesthetics for medical or cosmetic purposes. Use of products with the lowest amount of anesthetic with the least amount of application possible to relieve pain is also recommended.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Some products contain tartrazine and benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; avoid use of injection in neonates.",
"     <i>",
"      In vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein-binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F139865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F139866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1959662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F4627738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor patients for signs and symptoms of methemoglobinemia such as pallor, cyanosis, nausea, muscle weakness, dizziness, confusion, agitation, dyspnea, and tachycardia; co-oximetry",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks both the initiation and conduction of nerve impulses from sensory nerves by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1056777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Poor after topical administration to intact skin, but well absorbed from mucous membranes and traumatized skin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hydrolyzed in plasma and to a lesser extent in the liver by cholinesterase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Excretion of the metabolites in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1056771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?26/58/27557?source=see_link\">",
"      see \"Benzocaine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Consult healthcare provider for safe application practice prior to application; do not eat for 1 hour after application to oral mucosa; do not chew gum while mouth or throat is anesthetized due to potential biting trauma; do not overuse; do not apply to infected areas or to large areas of broken skin",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13008 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.181.191-2D925142A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11574=[""].join("\n");
var outline_f11_19_11574=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139882\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139883\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056772\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056768\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139869\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139856\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056775\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4627697\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056774\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139920\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139918\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056778\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056767\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298833\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139865\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139866\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1959662\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4627738\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056766\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056777\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056771\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13008\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13008|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=related_link\">",
"      Benzocaine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?26/58/27557?source=related_link\">",
"      Benzocaine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_19_11575="Kawasaki disease: Epidemiology and etiology";
var content_f11_19_11575=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Kawasaki disease: Epidemiology and etiology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Robert Sundel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Marisa Klein-Gitelman, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11575/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/19/11575/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kawasaki disease (KD, previously called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood, particularly in East Asia. It is typically a self-limited condition, with fever and other acute inflammatory manifestations lasting for an average of 12 days if not treated. The underlying etiology is unknown. Complications such as coronary artery aneurysm, cardiomyopathy with depressed myocardial contractility and heart failure, myocardial infarction, arrhythmias, and peripheral arterial occlusion may develop. These complications may cause significant morbidity and mortality. The frequency of aneurysm development and mortality has dramatically decreased as a result of intravenous immune globulin therapy. Early diagnosis is critical to achieve the optimal treatment result.",
"   </p>",
"   <p>",
"    The epidemiology and etiology of Kawasaki disease are reviewed here. The clinical features, diagnosis, treatment, and cardiac sequelae are presented separately. Incomplete Kawasaki disease is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=see_link\">",
"     \"Kawasaki disease: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42025?source=see_link\">",
"     \"Kawasaki disease: Initial treatment and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=see_link\">",
"     \"Cardiovascular sequelae of Kawasaki disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/34/11814?source=see_link\">",
"     \"Incomplete (atypical) Kawasaki disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kawasaki disease (KD) is one of the most common vasculitides of childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Geographic variation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of KD is greatest in children who live in East Asia or are of Asian ancestry living in other parts of the world [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The incidence in underdeveloped countries is largely unknown and ascertainment may be incomplete. KD is particularly difficult to diagnose in areas where measles is still prevalent, since the presentation is similar [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Many nations around the world have demonstrated an increase in the number of children diagnosed with KD since the early to mid 2000s. It is not clear, however, whether this represents an actual increase in the incidence of the disease, increased awareness of the condition, or a greater tendency to classify children with incomplete clinical features as having KD.",
"   </p>",
"   <p>",
"    The following studies illustrate the geographic and ethnic variation in the incidence of KD:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Japan &mdash; KD is a reportable disease in Japan and almost 250,000 cases of KD have been registered there since its initial description by Tomisaku Kawasaki in 1967 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. The incidence among children younger than five years of age was about 215 per 100,000 per year in 2007 and 2008, with the incidence in boys aged 0 to 4 years reaching as high as 240 per 100,000 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/8\">",
"       8",
"      </a>",
"      ]. The highest incidence was among children aged 6 to 11 months. Thus, about 1 in 100 Japanese children develops KD by the age of 5, making KD a very common illness in Japan.",
"      <br/>",
"      <br/>",
"      Although epidemics of KD were observed in Japan in 1979, 1982, and 1986, there has not been an epidemic since that time. However, incidence rates now exceed the rates observed during the three previous epidemics [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/8\">",
"       8",
"      </a>",
"      ]. In Japan, KD is most prevalent in the winter, with a smaller peak evident in summer [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Taiwan and China &mdash; Data from the Taiwan National Health Insurance Database indicate that the incidence of KD among children younger than five years was 69 per 100,000 per year between 2003 and 2006 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/9\">",
"       9",
"      </a>",
"      ]. A hospital-based survey of KD in all 45 hospitals in Beijing reported an increase in the incidence in children younger than five years of age from 41 per 100,000 in 2000 to 51 per 100,000 in 2004 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      United States &mdash; Studies of hospital discharge records by the United States Centers for Disease Control (CDC) estimated an overall annual incidence of 20 per 100,000 children younger than five years in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/11\">",
"       11",
"      </a>",
"      ]. Annual incidence was highest among Asians and Pacific Islanders (30 per 100,000), intermediate among non-Hispanic African Americans (17 per 100,000) and Hispanics (16 per 100,000), and lowest among Caucasians (12 per 100,000) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/11\">",
"       11",
"      </a>",
"      ]. A winter-spring predominance of cases is characteristic, and the peak incidence of illness is at less than one year of age [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/11\">",
"       11",
"      </a>",
"      ]. In contrast to Japan, surveillance in the United States is passive and many cases may be missed.",
"      <br/>",
"      <br/>",
"      The overall incidence was 22 per 100,000 children less than five years of age in San Diego County during a six-year period from 1998 to 2003 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/3\">",
"       3",
"      </a>",
"      ]. The rates based upon ethnicity were 15, 25, 20, and 46 per 100,000 children less than five years of age for non-Hispanic whites, non-Hispanic African Americans, Hispanics, and",
"      <span class=\"nowrap\">",
"       Asian/Pacific",
"      </span>",
"      Islanders, respectively.",
"     </li>",
"     <li>",
"      England &mdash; In an analysis of national admissions data in England, the annual incidence of KD for children under five years of age averaged 8 per 100,000 from 1998 to 2003 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/12\">",
"       12",
"      </a>",
"      ]. The incidences were higher for children of Chinese ethnicity, and those who lived in areas of greatest urban density and with the greatest degree of poverty.",
"     </li>",
"     <li>",
"      Israel &mdash; A retrospective study using the Israel National Hospital Discharge Register indicated an increase in KD incidence in Israel from 5 per 100,000 children under five years of age from 1996 to 1999 to 7 per 100,000 in 2000 to 2004 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/13\">",
"       13",
"      </a>",
"      ]. For male infants under one year of age, the KD incidence rate doubled between 1996 to 1998 and 1999 to 2009.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Other risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Boys are affected more commonly than girls [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/4,9,10,14,15\">",
"     4,9,10,14,15",
"    </a>",
"    ]. Eighty to 90 percent of cases occur in children younger than five [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/9,16\">",
"     9,16",
"    </a>",
"    ], although KD is relatively uncommon among children younger than six months (approximately 10 percent of KD hospitalizations in the US) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/11\">",
"     11",
"    </a>",
"    ]. Occurrence beyond late childhood is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/16,17\">",
"     16,17",
"    </a>",
"    ], although older children can develop KD and may experience delays in diagnosis and higher rates of coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Fewer than 100 cases of classic KD in adults had been reported in the literature at the time of a 2010 case series and review [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology of the illness is illustrated by an analysis of data from the Pediatric Health Information System (PHIS) that identified 4811 patients who were treated in 27 hospitals in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/4\">",
"     4",
"    </a>",
"    ]. The median age at first admission was 3.4 years (range 1 month to 21.3 years), and 60 percent of the patients were between one and four years of age. Sixty percent of patients were male. Patients of Asian ancestry were overrepresented in the KD group compared to the overall patient group contained within the PHIS dataset (6.9 versus 1.6 percent).",
"   </p>",
"   <p>",
"    In Japan, there is a reported 10-fold increased risk of KD for children with an affected sibling and a twofold increased risk for those with a previously affected parent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In North America, there are case reports of families with multiple affected members, but data are lacking to determine whether there is an increased familial risk for developing KD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     POSSIBLE ETIOLOGIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of KD remains unknown. A variety of theories have been proposed based upon pathologic, epidemiologic, and demographic data [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/24\">",
"     24",
"    </a>",
"    ]. Infection by one or more agents that usually cause an asymptomatic or nonvasculitic condition in most children, but results in KD in genetically predisposed individuals, fits the epidemiologic data well [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/25\">",
"     25",
"    </a>",
"    ] . This theory explains the paucity of cases in very young infants (who may be protected by passive maternal antibody), the rarity of cases in adults (who would have already experienced asymptomatic infection), and the scarcity of data showing person-to-person transmission (since most individuals would be infected asymptomatically).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Immunologic response",
"    </span>",
"    &nbsp;&mdash;&nbsp;KD is a systemic inflammatory illness that particularly affects medium-sized arteries, especially the coronary arteries. Pathologic studies indicate that multiple organs and tissues are involved [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/26\">",
"     26",
"    </a>",
"    ], but long-term sequelae appear to occur only in the arteries. Blood vessel damage appears to result from inflammatory cell infiltration into vascular tissues. The stimulus for this infiltration is unknown, but it is most profound in the coronary arteries and can involve destruction of luminal endothelial cells, elastic lamina, and medial smooth muscle cells in severe cases. The destruction of elastin and collagen fibers and loss of structural integrity of the arterial wall leads to dilatation and aneurysm formation. Inflammatory cells infiltrating the coronary arteries can include neutrophils, T cells (particularly CD8 T cells), eosinophils, plasma cells (particularly IgA-producing),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    macrophages.",
"   </p>",
"   <p>",
"    A neutrophilic infiltrate is observed in the arterial wall in fatalities that occur within the first two weeks of fever onset and may represent an innate immune response [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/27\">",
"     27",
"    </a>",
"    ]. A study of gene expression patterns in acute KD peripheral blood using DNA microarrays reflects the predominance of neutrophils early in the course of KD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/28\">",
"     28",
"    </a>",
"    ]. Expression of genes associated with neutrophils and inflammatory processes, including adrenomedullin, grancalcin, and granulin, was high during the acute phase of illness. Levels of these transcripts tended to decrease over time, while gene expression in CD8 T cells and natural killer (NK) cells increased as the illness evolved. CD8 T cells were prevalent in the arterial wall in fatalities that occur after two weeks in another study, consistent with the development of an acquired immune response [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/29\">",
"     29",
"    </a>",
"    ]. Gene expression in the peripheral blood from individual patients tended to be more consistent over time than did clustering by day of illness, suggesting the possibility that DNA polymorphisms affected individuals&rsquo; gene expression.",
"   </p>",
"   <p>",
"    Plasma cells producing oligoclonal IgA antibodies are found in the arteries of children with KD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/30\">",
"     30",
"    </a>",
"    ]. The distribution of IgA plasma cells in respiratory tract and arteries suggests that an etiologic agent (not yet identified) enters via the respiratory tract and spreads through the bloodstream to targeted susceptible organs, such as the coronary arteries. A synthetic monoclonal antibody derived from prevalent IgA sequences in the KD arterial wall identified intracytoplasmic inclusion bodies consistent with aggregates of proteins and nucleic acids in 85 percent of KD cases, but not in infant control tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Immune complexes are sometimes detected in the peripheral blood in KD, but they are not observed to form deposits in affected tissues and do not appear to correlate with the development of coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infectious etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many epidemiologic data suggest that KD is caused by a transmissible agent. Support for this theory is derived from the following similarities between KD and other pediatric infectious conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Kawasaki disease is characterized by a febrile exanthem with lymphadenitis and mucositis. These are features similar to those of contagious diseases such as adenovirus infection, measles, and scarlet fever.",
"     </li>",
"     <li>",
"      There is a seasonal increase in disease incidence in the winter and summer in many geographic areas [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The disease often occurs in epidemics [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/35,36\">",
"       35,36",
"      </a>",
"      ], and a geographic wave-like spread of illness during epidemics has been noted [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Boys are more susceptible than girls. In general, the &ldquo;set-point&rdquo; of the immune system varies between genders, leading to an overall higher incidence and morbidity of a variety of infections in males (eg, meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/37\">",
"       37",
"      </a>",
"      ], campylobacter enteritis [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/38\">",
"       38",
"      </a>",
"      ]), and a higher incidence of autoimmune diseases in females [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Siblings of children with KD in Japan are at increased risk for developing the disease, which usually occurs within one week of onset of the index case [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The disease is common among children younger than five years, but rare in those younger than six months. The rarity in infants may be explained by transfer of passive immunity to the relatively common infectious trigger(s) by transplacentally acquired maternal antibodies.",
"     </li>",
"     <li>",
"      There is spatial and temporal clustering of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cause of KD remains unknown despite clinical and epidemiologic data suggesting an infectious etiologic agent. Screening of patients with &ldquo;universal&rdquo; prokaryotic and eukaryotic primers has not identified an infectious agent as the cause. Thus, the significance of findings such as the presence of aggregates of particles that share morphologic features with several RNA virus families in a small number of patients with KD remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic factors appear to contribute to the pathogenesis of this disorder, as suggested by the increased frequency of the disease in Asian and Asian-American populations and among family members of an index case [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/1,21,41-43\">",
"     1,21,41-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Variants or polymorphisms of the following genes are associated with an increased susceptibility to KD:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inositol 1,4,5-trisphosphate 3-kinase C (",
"      <em>",
"       ITPKC",
"      </em>",
"      ) gene on chromosome 19q13.2 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. ITPKC acts as a negative regulator of T cell activation, which includes transcription of interleukin 2 (IL-2). The single nucleotide polymorphism (SNP) associated with KD susceptibility results in a weaker inhibitory effect upon T cell activation. Patients with this SNP may have a more vigorous T cell response during an inflammatory disease, such as KD, compared to those without this allelic change. However, this polymorphism is not common enough even in the Japanese population to explain the vast majority of cases of KD.",
"     </li>",
"     <li>",
"      Angiopoietin 1 (",
"      <em>",
"       ANGPT1",
"      </em>",
"      ) and vascular endothelial growth factor A (",
"      <em>",
"       VEGFA",
"      </em>",
"      ) genes [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]. Expression of angiopoietin 1 is upregulated, and VEGF downregulated, in patients with acute versus convalescent KD, suggesting disruption of vascular homeostasis.",
"     </li>",
"     <li>",
"      The genes encoding the chemokine receptor CCR5 and its major ligand CCL3L1 [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The gene for ATP-binding cassette, subfamily C, member 4 (ABCC4), a cyclic nucleotide transporter involved in migration of dendritic cells and cellular efflux of prostaglandin [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genome-wide association studies have revealed other potential susceptibility loci, including a functional polymorphism in the immunoglobulin G receptor gene (",
"      <em>",
"       FCGR2A",
"      </em>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/19/11575/abstract/51-55\">",
"       51-55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to being a putative susceptibility factor, ITPKC is associated with an increased risk of coronary artery aneurysms. Other genetic factors related to the development of coronary lesions in KD are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=see_link&amp;anchor=H242696532#H242696532\">",
"       \"Cardiovascular sequelae of Kawasaki disease\", section on 'Coronary artery aneurysm'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/8/3201?source=see_link\">",
"       \"Patient information: Kawasaki disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12069016\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Kawasaki disease (KD) is one of the most common vasculitides of childhood. The incidence of KD is greatest in children who live in East Asia (eg, Japan, Korea, Taiwan) or are of Asian ancestry living in other parts of the world. Other risk factors include male gender, age between six months and five years, and family history of KD. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of KD remains unknown. Inflammatory cell infiltration into KD vascular tissue leads to vascular damage, but the stimulus for this inflammatory infiltration has not been identified. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Immunologic response'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The similarities between KD and other pediatric infectious conditions suggest that KD is caused by a transmissible agent. However, no studies have convincingly identified a specific virus, bacteria or bacterial toxin, or other pathogen associated with KD. The etiology may be a previously unidentified infectious agent. An alternative theory to a specific inciting agent is that KD represents a final common pathway of immune-mediated vascular inflammation following a variety of inciting infections. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Infectious etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic factors appear to contribute to the pathogenesis of this disorder, as suggested by the increased frequency of the disease in Asian and Asian-American populations and among family members of an index case. A number of gene polymorphisms are associated with an increased susceptibility to KD, and some of these variants are also associated with coronary artery lesions and aneurysm formation. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Genetic factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/1\">",
"      Burns JC, Glod&eacute; MP. Kawasaki syndrome. Lancet 2004; 364:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/2\">",
"      Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/3\">",
"      Kao AS, Getis A, Brodine S, Burns JC. Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J 2008; 27:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/4\">",
"      Son MB, Gauvreau K, Ma L, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 2009; 124:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/5\">",
"      Davaalkham D, Nakamura Y, Baigalmaa D, et al. Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008. J Epidemiol 2011; 21:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/6\">",
"      Badoe EV, Neequaye J, Oliver-Commey JO, et al. Kawasaki disease in ghana: case reports from Korle Bu teaching hospital. Ghana Med J 2011; 45:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/7\">",
"      Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967; 16:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/8\">",
"      Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol 2010; 20:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/9\">",
"      Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123:e401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/10\">",
"      Du ZD, Zhao D, Du J, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J 2007; 26:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/11\">",
"      Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/12\">",
"      Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J 2009; 28:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/13\">",
"      Bar-Meir M, Haklai Z, Dor M. Kawasaki disease in Israel. Pediatr Infect Dis J 2011; 30:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/14\">",
"      Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998; 102:E65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/15\">",
"      Fischer TK, Holman RC, Yorita KL, et al. Kawasaki syndrome in Denmark. Pediatr Infect Dis J 2007; 26:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/16\">",
"      Yanagawa H, Yashiro M, Nakamura Y, et al. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995; 95:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/17\">",
"      Tomiyama J, Hasegawa Y, Kumagai Y, et al. Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in adults: case report and review of the literature. Jpn J Med 1991; 30:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/18\">",
"      Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/19\">",
"      Cai Z, Zuo R, Liu Y. Characteristics of Kawasaki disease in older children. Clin Pediatr (Phila) 2011; 50:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/20\">",
"      Gomard-Mennesson E, Landron C, Dauphin C, et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 2010; 89:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/21\">",
"      Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001; 90:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/22\">",
"      Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr 2003; 92:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/23\">",
"      Dergun M, Kao A, Hauger SB, et al. Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med 2005; 159:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/24\">",
"      Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol 2011; 164 Suppl 1:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/25\">",
"      Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 2005; 9:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/26\">",
"      Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/27\">",
"      Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 1991; 41:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/28\">",
"      Popper SJ, Shimizu C, Shike H, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007; 8:R261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/29\">",
"      Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001; 184:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/30\">",
"      Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/31\">",
"      Rowley AH, Baker SC, Shulman ST, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis 2005; 192:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/32\">",
"      Rowley AH, Baker SC, Shulman ST, et al. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One 2008; 3:e1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/33\">",
"      Mason WH, Jordan SC, Sakai R, et al. Circulating immune complexes in Kawasaki syndrome. Pediatr Infect Dis 1985; 4:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/34\">",
"      Rowley AH, Eckerley CA, J&auml;ck HM, et al. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997; 159:5946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/35\">",
"      Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology 2005; 16:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/36\">",
"      Yanagawa H, Nakamura Y, Yashiro M, et al. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 1988; 158:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/37\">",
"      de Jonge RC, van Furth AM, Wassenaar M, et al. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis 2010; 10:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/38\">",
"      Wang SC, Chang LY, Hsueh PR, et al. Campylobacter enteritis in children in northern Taiwan--a 7-year experience. J Microbiol Immunol Infect 2008; 41:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/39\">",
"      Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 2009; 11:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/40\">",
"      Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a \"new\" virus associated with Kawasaki disease. J Infect Dis 2011; 203:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/41\">",
"      Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch Pediatr Adolesc Med 2004; 158:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/42\">",
"      Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989; 84:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/43\">",
"      Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol 2010; 22:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/44\">",
"      Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/45\">",
"      Kuo HC, Yang KD, Juo SH, et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 2011; 6:e17370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/46\">",
"      Breunis WB, Biezeveld MH, Geissler J, et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 2006; 54:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/47\">",
"      Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009; 5:e1000319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/48\">",
"      Breunis WB, Davila S, Shimizu C, et al. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum 2012; 64:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/49\">",
"      Burns JC, Shimizu C, Gonzalez E, et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/50\">",
"      Khor CC, Davila S, Shimizu C, et al. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet 2011; 48:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/51\">",
"      Tsai FJ, Lee YC, Chang JS, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One 2011; 6:e16853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/52\">",
"      Kim JJ, Hong YM, Sohn S, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 2011; 129:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/53\">",
"      Khor CC, Davila S, Breunis WB, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011; 43:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/54\">",
"      Onouchi Y, Ozaki K, Burns JC, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012; 44:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11575/abstract/55\">",
"      Lee YC, Kuo HC, Chang JS, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012; 44:522.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6416 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-94E968098A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11575=[""].join("\n");
var outline_f11_19_11575=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12069016\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Geographic variation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Other risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      POSSIBLE ETIOLOGIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Immunologic response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infectious etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12069016\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=related_link\">",
"      Cardiovascular sequelae of Kawasaki disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/34/11814?source=related_link\">",
"      Incomplete (atypical) Kawasaki disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42025?source=related_link\">",
"      Kawasaki disease: Initial treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/8/3201?source=related_link\">",
"      Patient information: Kawasaki disease (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_19_11576="Toxoplasmosis of placenta";
var content_f11_19_11576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxoplasmosis of the placenta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 503px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Granulomatous villitis (B) Trophozoites.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11576=[""].join("\n");
var outline_f11_19_11576=null;
var title_f11_19_11577="Carbamazepine poisoning";
var content_f11_19_11577=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Carbamazepine poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Spencer Greene, MD, MS, FACEP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Ayrn O'Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/19/11577/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/19/11577/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    has been used for many years for the treatment of both partial and generalized seizures, as well as trigeminal neuralgia. It has also been used as a mood stabilizer and for treatment of neuropathic pain syndromes.",
"   </p>",
"   <p>",
"    In 2010, the American Association of Poison Control Centers reported 4282 toxic exposures to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/1\">",
"     1",
"    </a>",
"    ]. Of these, 2248 were reportedly isolated ingestions. Among the 1489 patients who sought treatment, there was one death and 538 patients who experienced moderate or major toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The toxicology, diagnosis, and management of acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning are discussed here. The clinical use of carbamazepine and chronic complications related to its use are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"     \"Pharmacology of antiepileptic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    interacts with multiple receptors and ion channels. Its therapeutic effect results from binding to sodium channels in their inactivated state, which inhibits neuron depolarization and decreases glutamate release [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/2\">",
"     2",
"    </a>",
"    ]. It is also anticholinergic, a property that is more relative in overdose than the therapeutic setting [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity, sodium channel blockade may manifest as cardiovascular toxicity, particularly prolongation of the QRS interval. This conduction abnormality predisposes patients to ventricular arrhythmias and hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    appears to have a paradoxical effect on adenosine receptors. In therapeutic doses, the drug inhibits presynaptic reuptake of adenosine, resulting in modulation and inhibition of glutamate neurotransmission [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In overdose, carbamazepine antagonizes adenosine receptors, resulting in a proconvulsant effect, which explains the seizure activity commonly seen in carbamazepine toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    is available in both immediate-release and controlled-release tablets and an immediate-release oral suspension. Absorption of therapeutic doses of an immediate-release formulation occurs in 3 to 12 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. In overdose, absorption is erratic and may be prolonged, with peak levels occurring over 96 hours after ingestion of a controlled-release formulation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8\">",
"     8",
"    </a>",
"    ]. The volume of distribution ranges from 0.8 to 1.8",
"    <span class=\"nowrap\">",
"     L/kg,",
"    </span>",
"    and protein binding is estimated to be between 75 and 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    undergoes hepatic metabolism, primarily through cytochrome P450 (CYP) 3A4 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/10\">",
"     10",
"    </a>",
"    ]. More than 30 metabolites have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/7,11\">",
"     7,11",
"    </a>",
"    ]. The most important of these are carbamazepine-10,11-epoxide, which has intrinsic anticonvulsant activity, and trans-10-11-dihydroxy-10,11-dihydrocarbamazepine, an arene oxide metabolite believed to be responsible for the hypersensitivity reactions and teratogenic effects of carbamazepine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    is a CYP 3A4 substrate as well as an inducer of multiple cytochrome P450 isoenzymes and may be subject to a number of drug-drug interactions (",
"    <a class=\"graphic graphic_table graphicRef76992 \" href=\"UTD.htm?9/45/9950\">",
"     table 1",
"    </a>",
"    ). Toxic levels of carbamazepine may result from CYP 3A4 inhibition due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    , among other drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/2,14,15\">",
"     2,14,15",
"    </a>",
"    ]. Conversely, CYP 3A4 inducers, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    , may decrease carbamazepine levels [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/10\">",
"     10",
"    </a>",
"    ]. Plasma levels of many medications, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/16,17\">",
"     16,17",
"    </a>",
"    ], are reduced in the setting of carbamazepine use. Carbamazepine induces its own metabolism, and dosage requirements increase when a patient takes the drug chronically [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    's elimination half-life demonstrates significant variability with therapeutic dosing, ranging from 12 to 17 hours following chronic therapeutic use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/2\">",
"     2",
"    </a>",
"    ]. The half-life can be significantly prolonged following overdose and averages 35 hours following a single overdose and 20 hours after multiple dosages [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/18\">",
"     18",
"    </a>",
"    ]. In overdose, carbamazepine's elimination is thought to display zero-order kinetics [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should consider the diagnosis of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity in any patient with cerebellar symptoms, central nervous system (CNS) depression, and signs of the anticholinergic toxidrome, particularly if the patient is known to have a seizure disorder or access to anticonvulsants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important historical information in the patient with suspected",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Identity of any ingested pills, including dose and formulation (eg, immediate-release or controlled-release)",
"     </li>",
"     <li>",
"      Approximate number of pills ingested",
"     </li>",
"     <li>",
"      Time of ingestion",
"     </li>",
"     <li>",
"      Whether the patient takes",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      or any other medication chronically",
"     </li>",
"     <li>",
"      Possible coingestants",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other helpful information includes symptoms prior to seeking medical care (such as vomiting, prolonged unconsciousness, or seizure activity) and whether any treatment was provided prior to arrival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Examination and clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    toxicity frequently presents with neurologic, cardiovascular, and anticholinergic symptoms. Patients with mild carbamazepine toxicity or those presenting shortly after the ingestion when absorption remains incomplete may demonstrate signs, such as drowsiness, nystagmus, and tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8,20-24\">",
"     8,20-24",
"    </a>",
"    ]. More severe intoxication may manifest as lethargy, seizure, coma, hypotension, or arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. Signs and symptoms of anticholinergic toxicity are expected. Toxicity may be prolonged due to carbamazepine's delayed and erratic absorption. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tachycardia is common following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    overdose. Hypotension is observed in moderate to severe poisoning and may be due to direct negative inotropic effects. Hyperthermia may be a result of anticholinergic effects (impaired heat dissipation) or from seizure activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/21,24\">",
"     21,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurologic examination typically reveals altered mental status. The patient may be agitated, but CNS depression, ranging from drowsiness to coma, is more common [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/20-26\">",
"     20-26",
"    </a>",
"    ]. Coma is often cyclical and consciousness may fluctuate abruptly from alert to comatose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/20,25\">",
"     20,25",
"    </a>",
"    ]. Ataxia and dysmetria (loss of coordinated movement) are common [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/22,25\">",
"     22,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seizures may occur, particularly in patients with underlying epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. Seizures may be self-limited or rarely, progress to status epilepticus [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/21,25\">",
"     21,25",
"    </a>",
"    ]. Myoclonus, hypertonia, hypotonia, and choreoathetosis have all been described in the setting of acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/23,24,27\">",
"     23,24,27",
"    </a>",
"    ]. A single case report has described sensorineural hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ocular examination frequently reveals nystagmus and mydriasis, and occasionally ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8,19,23,27\">",
"     8,19,23,27",
"    </a>",
"    ]. Oropharyngeal examination often reveals dry mucus membranes, and may show signs of trauma, which can occur from a fall due to a depressed level of consciousness or seizure activity.",
"   </p>",
"   <p>",
"    Abdominal examination may reveal hypoactive or absent bowel sounds and the urinary bladder may be palpable from urinary retention, both due to the anticholinergic effects of the drug. Abdominal tenderness is rare. Pancreatitis is rare, but has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skin may be hot, dry, and flushed and the axillae dry due to anticholinergic effects. One case report describes bullous eruptions following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    has been associated with leukopenia, agranulocytosis, and rarely, aplastic anemia. Other chronic side effects can include drug hypersensitivity and Stevens-Johnson syndrome. Chronic side effects from carbamazepine therapy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H3#H3\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Carbamazepine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=see_link&amp;anchor=H7#H7\">",
"     \"Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis\", section on 'Drugs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=see_link&amp;anchor=H31#H31\">",
"     \"Drug allergy: Classification and clinical features\", section on 'Drug-induced hypersensitivity syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    toxicity may present in a similar fashion to other poisonings as well as metabolic, infectious, or structural central nervous system (CNS) disorders.",
"   </p>",
"   <p>",
"    The toxicologic differential diagnosis is based largely on the presenting symptoms. If anticholinergic toxicity is present, anticholinergic agents (eg, tricyclic antidepressants, antihistamines, phenothiazines, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/60/13254?source=see_link\">",
"     cyclobenzaprine",
"    </a>",
"    ) should be considered. Cerebellar abnormalities and CNS depression should prompt consideration of sedative-hypnotic toxicity or toxic effects from other anticonvulsants, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , valproic acid, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    . Serum drug testing may help refine the differential diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link\">",
"     \"Tricyclic antidepressant poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41863?source=see_link\">",
"     \"Phenytoin poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28264?source=see_link\">",
"     \"Valproic acid poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=see_link\">",
"     \"Benzodiazepine poisoning and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Carbon monoxide (CO) poisoning can present with a variety of signs and symptoms that may resemble",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning. If CO poisoning is considered, a carboxyhemoglobin level should be obtained. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=see_link\">",
"     \"Carbon monoxide poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CNS pathology, especially cerebellar disease, can present with findings similar to acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning. Hypoglycemia, encephalitis-meningitis, status epilepticus, hepatic encephalopathy, subarachnoid hemorrhage, and stroke all may resemble carbamazepine toxicity. Hypoglycemia can be quickly excluded by finger-stick glucose testing. Neurologic imaging and analysis of the cerebrospinal fluid can distinguish many of these conditions from carbamazepine toxicity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44664?source=see_link\">",
"     \"Hypoglycemia in adults: Clinical manifestations, definition, and causes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=see_link\">",
"     \"Status epilepticus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/22/34153?source=see_link\">",
"     \"Clinical manifestations and diagnosis of hepatic encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"     \"Initial assessment and management of acute stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     General diagnostic testing in overdose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory evaluation of the poisoned patient should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serum carbamazepine concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    concentrations should be followed serially in an acute overdose. Serum concentrations may not peak for over 96 hours; levels should be obtained every four to six hours until there is a definite downward trend and the patient is improving clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8\">",
"     8",
"    </a>",
"    ]. Therapeutic concentrations of carbamazepine range from 4 to 12",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (17 to 51",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    relationship between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    levels and particular toxicities varies. Carbamazepine concentrations above 40",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    (170",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    correlate with an increased risk for apnea, dystonia, hypotension, and coma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/22,25,27,31\">",
"     22,25,27,31",
"    </a>",
"    ]. The relationship between the serum carbamazepine concentration and seizure risk is less consistent, but one small retrospective case series reported that seizures occurred exclusively in epileptic patients and with a serum carbamazepine concentration greater than 25",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ancillary testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, severe",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity can cause QRS prolongation and arrhythmia. Patients should be placed on continuous cardiac monitoring and a 12-lead electrocardiogram (ECG) should be obtained. Should QRS prolongation develop,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    should be administered and a repeat ECG obtained. (See",
"    <a class=\"local\" href=\"#H14450270\">",
"     'QRS interval prolongation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Sinus tachycardia is the most frequently observed cardiac effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , but bradycardia, atrioventricular block, premature ventricular contractions, ventricular tachycardia, and junctional escape rhythms have all been attributed to carbamazepine toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rhabdomyolysis may be present following an acute overdose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , if the patient has seized or experienced a prolonged period of unconsciousness. Creatine phosphokinase should be obtained initially and followed serially if elevated or if the history suggests the patient is at risk for rhabdomyolysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=see_link\">",
"     \"Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Imaging is not routinely needed following",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ingestion. However, if historical or examination findings suggest aspiration or pulmonary edema, a chest radiograph should be obtained. If the diagnosis is in question, concomitant pathology is suspected, or the patient has evidence of external head trauma, computed tomography of the head is indicated.",
"   </p>",
"   <p>",
"    If urine toxicology testing is performed,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    may trigger a false positive result for tricyclic antidepressants because of the drugs' structural similarity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Laboratory tests may reveal evidence of chronic toxicity. Examples include leukopenia, or rarely agranulocytosis, on a complete blood count [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/35\">",
"     35",
"    </a>",
"    ], or hyponatremia on a basic metabolic profile [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/36\">",
"     36",
"    </a>",
"    ]. Liver function tests (LFTs) are elevated in up to 30 percent of patients using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    chronically [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/20,37\">",
"     20,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Airway, breathing and circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with significant CNS depression may lose protective airway reflexes and should be intubated, particularly in light of their lower seizure threshold. Short-acting neuromuscular blocking agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    ) are preferable, so as not to mask subsequent seizure activity. Induction agents with GABA agonist activity (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    ) may be preferable depending upon the patient's hemodynamic status.",
"   </p>",
"   <p>",
"    Hypotension is initially treated with isotonic crystalloid. Caution should be exercised in patients at risk for volume overload, such as those with underlying heart disease or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    -induced myocardial dysfunction. Vasopressors are used if intravenous fluids fail to correct the hypotension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14450270\">",
"    <span class=\"h2\">",
"     QRS interval prolongation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sodium channel blockade may cause QRS interval prolongation and predispose to ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. QRS prolongation is treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    . A clear treatment threshold based upon the QRS duration has not been established. However, a reasonable practice is to give boluses of 100 to 150 meq of sodium bicarbonate intravenously for QRS intervals longer than 110 milliseconds, particularly in patients with hypotension. Repeat boluses may be required. Treatment with sodium bicarbonate is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link&amp;anchor=H15#H15\">",
"     \"Tricyclic antidepressant poisoning\", section on 'Sodium bicarbonate'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest avoiding class 1A (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ) and 1C (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/30/30182?source=see_link\">",
"     flecainide",
"    </a>",
"    ) antiarrhythmics in patients with acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning, although no studies have documented adverse effects from such treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures caused by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    overdose should be treated with agonists of gamma-aminobutyric acid (GABA), such as benzodiazepines (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    ).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    administered as a continuous infusion for the sedation of intubated patients also functions as an effective anticonvulsant. There is",
"    <strong>",
"     no role",
"    </strong>",
"    for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    in the management of drug-induced seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/40\">",
"     40",
"    </a>",
"    ]. Electroencephalogram monitoring may be necessary in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Activated charcoal",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     Activated charcoal",
"    </a>",
"    (AC) remains the most common method of gastrointestinal (GI) decontamination for acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning, although its effectiveness in improving clinical outcomes has not been proven [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/41\">",
"     41",
"    </a>",
"    ]. The role of GI decontamination in the management of acute overdose is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is acceptable to give a single dose of AC (1",
"    <span class=\"nowrap\">",
"     g/kg;",
"    </span>",
"    maximum dose 50 g) to patients with a normal mental status who present within one to two hours of an acute overdose and are able to protect their airway [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. AC should be withheld in unintubated patients with CNS sedation who may not be able to protect their airway. We do",
"    <strong>",
"     NOT",
"    </strong>",
"    recommend that endotracheal intubation be performed solely for the purpose of giving charcoal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Multidose activated charcoal",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of severe",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning, multiple dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (MDAC) may be warranted. We suggest that treatment with MDAC be given in consultation with a medical toxicologist or poison control center. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Additional resources'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     Carbamazepine",
"    </a>",
"    demonstrates prolonged absorption and enterohepatic circulation in overdose, and some toxicologists advocate treatment with MDAC to prevent absorption and enhance elimination. Multiple reports claim that MDAC enhances elimination, and both the American Academy of Clinical Toxicologists and the European Association of Poisons Centres and Clinical Toxicologists recommend that treatment with MDAC be considered following carbamazepine ingestions resulting in serious or life-threatening signs and symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/41,44-47\">",
"     41,44-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, few controlled trials have demonstrated improved outcome from treatment with MDAC. One study comparing MDAC (50 grams every six hours) to single dose AC (1",
"    <span class=\"nowrap\">",
"     g/kg)",
"    </span>",
"    found that the MDAC group had shorter periods of coma, mechanical ventilation, and hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/46\">",
"     46",
"    </a>",
"    ]. However, the use of MDAC is often limited in the setting of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity due to decreased gastrointestinal motility. Carbamazepine's anticholinergic effects often cause decreased motility, ileus, or even bowel obstruction, which precludes therapy with MDAC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Other methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no role for other types of GI decontamination for acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    poisoning. Whole bowel irrigation after ingestion of sustained release tablets failed to reduce absorption in several reported cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8,48,49\">",
"     8,48,49",
"    </a>",
"    ], and we do",
"    <strong>",
"     NOT",
"    </strong>",
"    advocate its use. Gastric emptying (by syrup of ipecac or gastric lavage) is",
"    <strong>",
"     NOT",
"    </strong>",
"    recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Extracorporeal elimination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extracorporeal removal of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    is reserved for severely poisoned patients who are deteriorating despite maximum supportive care.",
"   </p>",
"   <p>",
"    It remains questionable whether hemodialysis enhances the elimination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    . At therapeutic levels, carbamazepine is highly protein bound, limiting the effectiveness of hemodialysis. However, in overdose, the proportion of free drug increases, theoretically making this approach more effective. Evidence supporting the use of hemodialysis is limited to case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/52-56\">",
"     52-56",
"    </a>",
"    ]. Elimination rates are comparable to those achieved with charcoal hemoperfusion. However, charcoal hemoperfusion is often difficult to obtain [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/8,52,57-60\">",
"     8,52,57-60",
"    </a>",
"    ], and the procedure has risks (thrombocytopenia, coagulopathy, hypothermia, hypocalcemia, hypophosphatemia, and hypoglycemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/57-60\">",
"     57-60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plasmapheresis and plasma exchange have been used to enhance",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    elimination [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/61\">",
"     61",
"    </a>",
"    ], but outcome data are limited and their use cannot be recommended, pending further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Physostigmine",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do",
"    <strong>",
"     NOT",
"    </strong>",
"    recommend the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/27/40372?source=see_link\">",
"     physostigmine",
"    </a>",
"    to treat patients suffering anticholinergic effects from acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    toxicity. Physostigmine's half-life is significantly shorter than carbamazepine's, and its therapeutic effects are transient compared to carbamazepine's toxicity. Moreover, carbamazepine's toxicity is not due solely to anticholinergic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/62\">",
"     62",
"    </a>",
"    ]. The use of physostigmine for anticholinergic poisoning is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link&amp;anchor=H11#H11\">",
"     \"Anticholinergic poisoning\", section on 'Antidotal therapy with physostigmine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhabdomyolysis requires aggressive hydration with intravenous fluids. Aspiration may warrant antibiotic therapy; mechanical ventilation may be necessary for respiratory failure. Hyponatremia may require urgent correction depending upon the rate and degree of the fall in the serum sodium concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=see_link\">",
"     \"Overview of the treatment of hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=see_link&amp;anchor=H25398978#H25398978\">",
"     \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 34 percent of isolated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    exposures reported in 2010 occurred in children less than 19 years old, and more than half of those were in patients under six years old [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most pediatric ingestions produce only mild toxicity due to their accidental nature, and are characterized by ataxia, nystagmus, drowsiness, and emesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/19,27,63,64\">",
"     19,27,63,64",
"    </a>",
"    ]. Peripheral anticholinergic signs are frequently absent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/27,63\">",
"     27,63",
"    </a>",
"    ]. The serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    concentration at which more severe manifestations of toxicity develop is estimated to be lower than that of adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/27,64\">",
"     27,64",
"    </a>",
"    ]. According to one case series, children with a serum carbamazepine concentration above 28",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    (117",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    are at highest risk of coma and apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?11/19/11577/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       Carbamazepine",
"      </a>",
"      toxicity frequently presents with neurologic and cardiovascular symptoms. Patients with mild carbamazepine toxicity, or those presenting shortly after ingestion, may demonstrate signs such as drowsiness, nystagmus, and tachycardia. Severe intoxication may manifest as lethargy, seizure, coma, hypotension, or arrhythmia. Signs and symptoms of anticholinergic toxicity are expected. Toxicity may be prolonged due to carbamazepine's delayed and erratic absorption. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Kinetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important historical information in the patient with suspected",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      poisoning includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Identity of any ingested pills, including dose and formulation (eg, immediate-release or controlled-release)",
"     </li>",
"     <li>",
"      Time of ingestion",
"     </li>",
"     <li>",
"      Whether the patient takes",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      or any other medication chronically",
"     </li>",
"     <li>",
"      Possible coingestants (see",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With acute",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      overdose, tachycardia is common. Hypotension may occur in more severe poisoning. Hyperthermia may result from anticholinergic effects or seizure activity. The patient may be agitated, but central nervous system (CNS) depression, ranging from drowsiness to coma, is more common. Fluctuations in consciousness are classically encountered in carbamazepine toxicity. Seizures can occur. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Examination and clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       Carbamazepine",
"      </a>",
"      toxicity may present in a similar fashion to other poisonings (eg, anticholinergics, anticonvulsants, sedative hypnotics), as well as metabolic and other non-toxicologic disorders. Considerations include carbon monoxide poisoning, hypoglycemia, CNS infection, intracranial hemorrhage, and stroke. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      concentrations should be followed serially in an acute overdose. Concentrations may not peak for a few days; levels should be obtained every four to six hours until there is a definite downward trend and the patient is improving clinically. Other useful diagnostic tests (including electrocardiograms) are described in the text. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with significant CNS depression may lose protective airway reflexes and should be intubated. Short-acting neuromuscular blocking agents (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"       succinylcholine",
"      </a>",
"      ) are preferable, so as not to mask subsequent seizure activity. Induction agents with antiepileptic effects (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      ) may be preferable depending upon the patient's hemodynamic status. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Airway, breathing and circulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treat hypotension initially with isotonic crystalloid. Sodium channel blockade from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      overdose may cause QRS prolongation and predispose to ventricular arrhythmias. We suggest that QRS prolongation caused by carbamazepine poisoning be treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). One approach is to give boluses of 100 to 150 meq of sodium bicarbonate intravenously for QRS intervals longer than 100 milliseconds. Treatment with sodium bicarbonate is described in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link&amp;anchor=H15#H15\">",
"       \"Tricyclic antidepressant poisoning\", section on 'Sodium bicarbonate'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that seizures caused by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      overdose be treated with GABA agonists such as benzodiazepines (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). There is",
"      <strong>",
"       no role",
"      </strong>",
"      for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      or other anticonvulsants. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Seizures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is acceptable to give a single dose of AC (1",
"      <span class=\"nowrap\">",
"       g/kg;",
"      </span>",
"      maximum dose 50 g) to patients with a normal mental status who present within one to two hours of an acute",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      overdose and are able to protect their airway. AC should be withheld in unintubated patients with CNS depression. We do",
"      <strong>",
"       NOT",
"      </strong>",
"      recommend that tracheal intubation be performed solely for the purpose of giving charcoal. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/1\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011; 49:910.",
"     </a>",
"    </li>",
"    <li>",
"     Novartis Pharmaceuticals USA. Prescribing information for Tegretol CR400(R) tablets www.pharma.us.novartis.com/product/pi/pdf/tegretol.pdf (Accessed on August 27, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/3\">",
"      Spiller HA. Management of carbamazepine overdose. Pediatr Emerg Care 2001; 17:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/4\">",
"      Starmer CF, Lastra AA, Nesterenko VV, Grant AO. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments. Circulation 1991; 84:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/5\">",
"      Fujiwara Y, Sato M, Otsuki S. Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors. Psychopharmacology (Berl) 1986; 90:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/6\">",
"      Van Calker D, Steber R, Klotz KN, Greil W. Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol 1991; 206:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/7\">",
"      Kanarkowski R, Rybakowski J. [Clinical pharmacokinetics of carbamazepine]. Psychiatr Pol 1989; 23:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/8\">",
"      Graudins A, Peden G, Dowsett RP. Massive overdose with controlled-release carbamazepine resulting in delayed peak serum concentrations and life-threatening toxicity. Emerg Med (Fremantle) 2002; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/9\">",
"      Vree TB, Janssen TJ, Hekster YA, et al. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Ther Drug Monit 1986; 8:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/10\">",
"      Spina E, Martines C, Fazio A, et al. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Ther Drug Monit 1991; 13:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/11\">",
"      Kanarkowski R, Wankiewicz G, Lehmann W, Rybakowski J. Pharmacokinetics of carbamazepine in psychiatric patients. Pol J Pharmacol Pharm 1988; 40:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/12\">",
"      Yoo JH, Kang DS, Chun WH, et al. Anticonvulsant hypersensitivity syndrome with an epoxide hydrolase defect. Br J Dermatol 1999; 140:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/13\">",
"      Hundt HK, Aucamp AK, M&uuml;ller FO. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol 1983; 2:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/14\">",
"      Goulden KJ, Camfield P, Dooley JM, et al. Severe carbamazepine intoxication after coadministration of erythromycin. J Pediatr 1986; 109:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/15\">",
"      Tagawa T, Mimaki T, Ono J, et al. Erythromycin-induced carbamazepine intoxication in two epileptic children. Jpn J Psychiatry Neurol 1989; 43:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/16\">",
"      Jerling M, Lindstr&ouml;m L, Bondesson U, Bertilsson L. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 1994; 16:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/17\">",
"      Iwahashi K, Miyatake R, Suwaki H, et al. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels. Clin Neuropharmacol 1995; 18:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/18\">",
"      Winnicka RI, Topaci��ski B, Szymczak WM, Szyma��ska B. Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol 2002; 40:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/19\">",
"      Perez A, Wiley JF. Pediatric carbamazepine suspension overdose-clinical manifestations and toxicokinetics. Pediatr Emerg Care 2005; 21:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/20\">",
"      Durelli L, Massazza U, Cavallo R. Carbamazepine toxicity and poisoning. Incidence, clinical features and management. Med Toxicol Adverse Drug Exp 1989; 4:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/21\">",
"      Spiller HA, Carlisle RD. Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 2002; 40:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/22\">",
"      Tibballs J. Acute toxic reaction to carbamazepine: clinical effects and serum concentrations. J Pediatr 1992; 121:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/23\">",
"      O'Neal W Jr, Whitten KM, Baumann RJ, et al. Lack of serious toxicity following carbamazepine overdosage. Clin Pharm 1984; 3:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/24\">",
"      Fisher RS, Cysyk B. A fatal overdose of carbamazepine: case report and review of literature. J Toxicol Clin Toxicol 1988; 26:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/25\">",
"      Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol 1993; 31:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/26\">",
"      Seymour JF. Carbamazepine overdose. Features of 33 cases. Drug Saf 1993; 8:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/27\">",
"      Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbamazepine intoxication. Ann Emerg Med 1995; 25:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/28\">",
"      de la Cruz M, Bance M. Carbamazepine-induced sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1999; 125:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/29\">",
"      Tsao CY, Wright FS. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993; 34:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/30\">",
"      Godden DJ, McPhie JL. Bullous skin eruption associated with carbamazepine overdosage. Postgrad Med J 1983; 59:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/31\">",
"      Brahmi N, Kouraichi N, Abderrazek H, et al. Clinical experience with carbamazepine overdose: relationship between serum concentration and neurological severity. J Clin Psychopharmacol 2008; 28:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/32\">",
"      George S, Braithwaite RA. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction 1995; 90:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/33\">",
"      Fleischman A, Chiang VW. Carbamazepine overdose recognized by a tricyclic antidepressant assay. Pediatrics 2001; 107:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/34\">",
"      Saidinejad M, Law T, Ewald MB. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants. Pediatrics 2007; 120:e504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/35\">",
"      Sobotka JL, Alexander B, Cook BL. A review of carbamazepine's hematologic reactions and monitoring recommendations. DICP 1990; 24:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/36\">",
"      Kuz GM, Manssourian A. Carbamazepine-induced hyponatremia: assessment of risk factors. Ann Pharmacother 2005; 39:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/37\">",
"      Mayoral W, Lewis JH. Drug-induced liver disease. Curr Opin Gastroenterol 2000; 16:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/38\">",
"      Bradberry SM, Thanacoody HK, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning : role of sodium bicarbonate. Toxicol Rev 2005; 24:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/39\">",
"      Liebelt EL. Targeted management strategies for cardiovascular toxicity from tricyclic antidepressant overdose: the pivotal role for alkalinization and sodium loading. Pediatr Emerg Care 1998; 14:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/40\">",
"      Cave G, Sleigh JW. ECG features of sodium channel blockade in rodent phenytoin toxicity and effect of hypertonic saline. Vet Hum Toxicol 2003; 45:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/41\">",
"      Mise S, Juki�� I, Tonki�� A, et al. Multidose activated charcoal in the treatment of carbamazepine overdose with seizures: a case report. Arh Hig Rada Toksikol 2005; 56:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/42\">",
"      Chyka PA, Seger D, Krenzelok EP, et al. Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/43\">",
"      Greene S, Harris C, Singer J. Gastrointestinal decontamination of the poisoned patient. Pediatr Emerg Care 2008; 24:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/44\">",
"      Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1999; 37:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/45\">",
"      Wason S, Baker RC, Carolan P, et al. Carbamazepine overdose--the effects of multiple dose activated charcoal. J Toxicol Clin Toxicol 1992; 30:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/46\">",
"      Brahmi N, Kouraichi N, Thabet H, Amamou M. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med 2006; 24:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/47\">",
"      Montoya-Cabrera MA, Sauceda-Garc&iacute;a JM, Escalante-Galindo P, et al. Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination. Arch Med Res 1996; 27:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/48\">",
"      Position paper: whole bowel irrigation. J Toxicol Clin Toxicol 2004; 42:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/49\">",
"      Lurie Y, Bentur Y, Levy Y, et al. Limited efficacy of gastrointestinal decontamination in severe slow-release carbamazepine overdose. Ann Pharmacother 2007; 41:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/50\">",
"      Vale JA, Kulig K, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. J Toxicol Clin Toxicol 2004; 42:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/51\">",
"      Position paper: Ipecac syrup. J Toxicol Clin Toxicol 2004; 42:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/52\">",
"      Bek K, Ko&ccedil;ak S, Ozkaya O, et al. Carbamazepine poisoning managed with haemodialysis and haemoperfusion in three adolescents. Nephrology (Carlton) 2007; 12:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/53\">",
"      Chetty M, Sarkar P, Aggarwal A, Sakhuja V. Carbamazepine poisoning: treatment with haemodialysis. Nephrol Dial Transplant 2003; 18:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/54\">",
"      Schuerer DJ, Brophy PD, Maxvold NJ, et al. High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 2000; 38:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/55\">",
"      Li TG, Yan Y, Wang NN, Zhao M. Acute carbamazepine poisoning treated with resin hemoperfusion successfully. Am J Emerg Med 2011; 29:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/56\">",
"      Harder JL, Heung M, Vilay AM, et al. Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose. Hemodial Int 2011; 15:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/57\">",
"      Deshpande G, Meert KL, Valentini RP. Repeat charcoal hemoperfusion treatments in life threatening carbamazepine overdose. Pediatr Nephrol 1999; 13:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/58\">",
"      Leslie PJ, Heyworth R, Prescott LF. Cardiac complications of carbamazepine intoxication: treatment by haemoperfusion. Br Med J (Clin Res Ed) 1983; 286:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/59\">",
"      Cameron RJ, Hungerford P, Dawson AH. Efficacy of charcoal hemoperfusion in massive carbamazepine poisoning. J Toxicol Clin Toxicol 2002; 40:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/60\">",
"      Pilapil M, Petersen J. Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose. Clin Toxicol (Phila) 2008; 46:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/61\">",
"      Duzova A, Baskin E, Usta Y, Ozen S. Carbamazepine poisoning: treatment with plasma exchange. Hum Exp Toxicol 2001; 20:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/62\">",
"      Burns MJ, Linden CH, Graudins A, et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 2000; 35:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/63\">",
"      Macnab AJ, Birch P, Macready J. Carbamazepine poisoning in children. Pediatr Emerg Care 1993; 9:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/19/11577/abstract/64\">",
"      Lifshitz M, Gavrilov V, Sofer S. Signs and symptoms of carbamazepine overdose in young children. Pediatr Emerg Care 2000; 16:26.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 332 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11577=[""].join("\n");
var outline_f11_19_11577=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Examination and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      General diagnostic testing in overdose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serum carbamazepine concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ancillary testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Airway, breathing and circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14450270\">",
"      QRS interval prolongation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Activated charcoal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Multidose activated charcoal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Other methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Extracorporeal elimination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Physostigmine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/332\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/332|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/45/9950\" title=\"table 1\">",
"      Inhibitors and inducers of cytochrome P450 3A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=related_link\">",
"      Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=related_link\">",
"      Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/22/34153?source=related_link\">",
"      Clinical manifestations and diagnosis of hepatic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=related_link\">",
"      Drug allergy: Classification and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44664?source=related_link\">",
"      Hypoglycemia in adults: Clinical manifestations, definition, and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18986?source=related_link\">",
"      Overview of the treatment of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=related_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41863?source=related_link\">",
"      Phenytoin poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=related_link\">",
"      Tricyclic antidepressant poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28264?source=related_link\">",
"      Valproic acid poisoning",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_19_11578="Mycosis fungoides patch";
var content_f11_19_11578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80073%7EDERM%2F60650%7EDERM%2F71926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80073%7EDERM%2F60650%7EDERM%2F71926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subtle erythematous patches with slight scale are present on the buttocks of this patient with mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycosis fungoides - patch stage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous patches are present on the trunk and proximal extremities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypopigmented mycosis fungoides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypopigmented patches are present in this patient with mycosis fungoides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11578=[""].join("\n");
var outline_f11_19_11578=null;
var title_f11_19_11579="Components of second and third trimester ultrasound examinations";
var content_f11_19_11579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Components of second and third trimester ultrasound examinations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Presence or absence of fetal cardiac activity, cardiac rate and rhythm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal number",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal presentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assessment of amniotic fluid volume",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placental appearance and location",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal biometry (biparietal diameter and/or head circumference, femoral length, abdominal diameter and/or circumference)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Evaluation of the uterus, cervix, adnexa when clinically appropriate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal anatomic survey",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Biometry can be used to estimate gestational age (if not previously determined), fetal weight, and fetal growth (by comparing two or more examinations over an appropriate time interval).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11579=[""].join("\n");
var outline_f11_19_11579=null;
var title_f11_19_11580="Infections causes of hydrops";
var content_f11_19_11580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infections associated with nonimmune hydrops",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Pathogen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Screening",
"       </td>",
"       <td class=\"subtitle1\">",
"        Therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytomegalovirus",
"       </td>",
"       <td>",
"        Virus antigen in amniotic fluid",
"       </td>",
"       <td>",
"        None approved",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herpes simplex",
"       </td>",
"       <td>",
"        Cultureamniotic fluid or fetal tissue",
"       </td>",
"       <td>",
"        Acyclovir for maternal indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Parvovirus B19",
"       </td>",
"       <td>",
"        Maternal IgM, IgG",
"       </td>",
"       <td>",
"        Close observation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PCR amniotic fluid, fetal blood",
"       </td>",
"       <td>",
"        In-utero transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rubella virus",
"       </td>",
"       <td>",
"        Fetal body fluid IgM",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coxsackievirus",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Varicella Zoster",
"       </td>",
"       <td>",
"        Maternal IgM",
"       </td>",
"       <td>",
"        Acyclovir for maternal indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syphilis",
"       </td>",
"       <td>",
"        Non-treponemal and treponemal serology",
"       </td>",
"       <td>",
"        Penicillin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxoplasmodium gondii",
"       </td>",
"       <td>",
"        Maternal or placental IgM, IgG; amniotic fluid PCR",
"       </td>",
"       <td>",
"        Spiramycin with sulfadiazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tryponosoma cruzii (Chagas disease)",
"       </td>",
"       <td>",
"        Maternal serology for T. cruzii",
"       </td>",
"       <td>",
"        Benznidazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adenovirus",
"       </td>",
"       <td>",
"        Maternal IgM, IgG, PCR and serology",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coxsackievirus",
"       </td>",
"       <td>",
"        Maternal serology",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11580=[""].join("\n");
var outline_f11_19_11580=null;
var title_f11_19_11581="Driver's with pacemakers";
var content_f11_19_11581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79800&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79800&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for certification for commercial drivers with pacemakers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Physiologic/functional",
"       </td>",
"       <td class=\"subtitle1\">",
"        Certification",
"       </td>",
"       <td class=\"subtitle1\">",
"        Re-certification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Sinus node dysfunction",
"       </td>",
"       <td rowspan=\"5\">",
"        Variable long-term prognosis depending on underlying disease, but cerebral hypoperfusion corrected by support of heart rate by pacemaker",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Yes if:",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Annual",
"        </p>",
"        <p>",
"         Documented pacemaker checks",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - 1 month after pacemaker implantation and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Documented correct function by pacemaker center and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Underlying disease is not disqualifying",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Atrioventricular (AV) block",
"       </td>",
"       <td rowspan=\"5\">",
"        Variable long-term prognosis depending on underlying disease, but cerebral hypoperfusion corrected by support of heart rate by pacemaker",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Yes if:",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Annual",
"        </p>",
"        <p>",
"         Documented pacemaker checks",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - 1 month after pacemaker implantation and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Documented correct function by pacemaker center and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Underlying disease is not disqualifying",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Neurocardiogenic syncope",
"       </td>",
"       <td rowspan=\"5\">",
"        <p>",
"         Excellent long-term survival prognosis but there is risk for syncope that may be due to cardioinhibitory (slowing heart rate) or vasodepressor (drop in blood pressure) components, or both",
"        </p>",
"        <p>",
"         Pacemaker will affect only cardioinhibitory component, but will lessen effect of vasodepressor component",
"        </p>",
"       </td>",
"       <td>",
"        No, with symptoms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Yes if:",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Annual",
"        </p>",
"        <p>",
"         Documented pacemaker checks",
"        </p>",
"        <p>",
"         Absence of symptom recurrence",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - 3 months* after pacemaker implantation and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Documented correct function by pacemaker center and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Absence of symptom recurrence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Hypersensitive carotid sinus with syncope",
"       </td>",
"       <td rowspan=\"5\">",
"        <p>",
"         Excellent long-term survival prognosis but there is risk for syncope that may be due to cardioinhibitory (slowing heart rate) or vasodepressor (drop in blood pressure) components, or both",
"        </p>",
"        <p>",
"         Pacemaker will affect only cardioinhibitory component, but will lessen effect of vasodepressor component",
"        </p>",
"       </td>",
"       <td>",
"        No, with symptoms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Yes if:",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Annual",
"        </p>",
"        <p>",
"         Documented regular pacemaker checks and",
"        </p>",
"        <p>",
"         Absence of symptom recurrence",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - 3 months* after pacemaker implantation and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Documented correct function by pacemaker center and",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Absence of symptom recurrence",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Three months recommended due to possible vasodepressor component of syndrome not necessarily treated by pacing.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Blumenthal R, Braunstein J, Connolly H, et al. Cardiovascular Advisory Panel Guidelines for the Medical Examination of Commercial Motor Vehicle Drivers, October 2002. Federal Motor Carrier Safety Administration.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11581=[""].join("\n");
var outline_f11_19_11581=null;
var title_f11_19_11582="Glucocorticoid structure";
var content_f11_19_11582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53204&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    Glucocorticoid structure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 338px; background-image: url(data:image/gif;base64,R0lGODlh0AFSAeYAAP///2YzZgAAADMZM4CAgMDAwEBAQPDw8CAgIEwmTBAQEIxmjODg4AYDBl8vX6CgoBkMGQwGDCYTJmBgYFksWdjM2DAwMD8fP9DQ0LKZsnBwcFBQUJCQkLCwsB8PH4JZguLY4jkcOW8/b0YjRn9/f+vl63lMeSwWLBMJE6iMqFIpUp9/n7ylvMWyxfXy9c+/zz8/P5Vyld/f35+fn7+/vy8vLx8fH+/v74+Pj6+vr29vb09PTw8PD8/Pz19fX4yFjD8vP4VihYVyhWxWbGk8aVJJUkk8SVYzVpmMmcXCxbWytQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADQAVIBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSLCgwYMIEypcyLChw4cQcTHgQODBAQAYClw8UAADogMUOVwEwNEjRo0RUyJ8IKClAAMADAgoAKDAy0MYFCiQqcCjTZgxZ6ocOpCBAAU0MRAISvPnIQQCPGIQgKDmTaZEs/7jIEBDIZkTCEy4SmiqhUEWotpEQIAAVJpa/+PqIyBgKSGZLskOcipIZgGbeYXKHWyPJVAADLA6faDg5YEDRwc15njVL+HL9KAaILABpmWnHRhMXapBwIYCG7paBWoZs+t3DFJT5aCYrNEHgtxStcu39evf+g5YOAu8OEIGFgyMNM58IF69zaNLn069uvXrplpi3z5PO/fv7ryDH59OPPnz5MyjX/9NPfv32tzDn19NPv370Ozj379MP///xvgH4IAEFmjggQfKgAMJM9ywiAwkkIAbghSuMkNeMChyoQ01CGDBchWGKIoMAvBAAwA9kACADDS02GIPKwpgg4NcTSDijaHgIIAOhZAQWIY68khSZDgWyYmPKjKC5P8gAhrppCMXZiiIDADMAMOVV/KYgwA7CGLWk2BaYoMAMJCwQ4Y0RKjmDIJ0SEIOaXUQ5pySyLBDSzbgoMgNPvDgoZx0BirooIQWak2Thia6CKKKNmoIo45GCgCkkjZKaaWJXoppoZpuOminngYKaqhzjkoqmKaealxHgxzwAAEijZKqqq8pdZVwLx0Foiez0ooZXkDZdJZvn/Tq62V84WoBAjaKYuyxgyU7gQJQfeisANCSxxdXS6VmFyjPZpsVBlxZoBFL5qY1IbjYisvdc0Jp0Bhbsrbrbqb23stpvvpuFy4j/xYCIYODsEhlTXD1+0/AijAsyIYd1uDgkpPyq/D/Pg4j4jCJMwKgow8AUJzxxd6M/KjFmgQpyA0lhkxmhCaTvE3MhDhMccUuByZzPzQzWVdbQAMNVwFBF03A0EcPsmWXKApQg8tJ9rzzKhzQhorUFUewW9FIGy20IEQnDICbOXSYA9SCYD21KQUYEEEEBohdrykPIBDBCAFcEAEC62bCp581nI02zmsrw4ABDYQQgAMDNDBBYqTEXHcEFwRgueV6IwBo4bBN0MAADlweAAUSKEDArryivEnblIvu+gUNbIA65+YcQIACElDg+uUJQMD3taAw4Dnou7vugAcKbE67ORwoAIHuxYuud9zsemI77tBH7/oIsc++fDd1Q5CA//a7M+445Jz82wEC4pMf/fEK9P3OX3+dynrlly/wweUmpJBBCiJwHelM5z1KPOsAG2gA/tynvRHsTX7syEv8NnW4xInuAxkAQAUuV4FBgKB4vfudJozVAQV4IHSi05/lRLCAFrYwgNHLHATLgy3kCMY19UNMASAHElgVUBXC+xwKOSiIDVouBiIQQQkAsIAYwk1uBlQdJBDYALxdMINGXEAhmkg+GbbDOyzZwG+8Q5el5GQnRzGJK66Xu+hp0YiiW6IJtGe+x10iVSU84e46qMEVtnAFgpgjA72oDu/wxTVkrAsAoCIVqryiec8j3xtdlwIAsICBAzxdJUZFRSsWb/+SomsBAFrAQOntTXnlAKMAmoXIn8mEAF8SRFrUmIr1tc99oLQcC0ZZSsuFcIaNABVj9Ki9XAbABIHspfS6h4wCcEADBkhLYPKSHA1wAIqFaEkBGKMA9GFmmkcjC7FMUcEFku8DlQTBAgL4AgCUIAMZ4GIpp4fNRUkxEZPzZDH7eDlRklKZooMfKn2BAQ1IEwGbORr9FlqADrTFAFDxkAZo6bOWbICil0nk6YgEgMl4yRS3O8EQ3cdHQTSxEBkAaABC0AADeBNg9zTE5MypPXQCQJ0B1CIABKnSy3FPdgSVl0Q78MOPdMCgR5modTQKgNKcJjVeEQQC2PJSThTAAij/UEFPt0q+OlZVYzEdxEyVWVImBqCDl+Tq5QS6iwfIxAIc+OokJpIWAwzUOEwFgG7o5aWImuauljiA5xSn1sIWL5NFJZwixmrYxm6Pmba46irriYkCjMVc8+mAbHYj10gMM3uODS0FIKAAqyXCP4wNrWoXhzxgsgKBpunsJmJjmsRuhwG6sShgG3G4CIxvtcD95WlVdz/gGjcADqQeLApALcp+ogAIQMp9NOsSqk6RLsQ7LnDpeQj3BDG72l2tV13BkgnYthOCFYBrz4Nbv25gt4SALgS0Gt7jstSl2cwXG0Fb39UidhUs+dYq6LJe9FC3JdY9BBVp2l/xNs6OabNX//h+22DtChcVHVAvLFgC3/W01yXvLUTzJDDSChv3v9pJrYnDS0hSMEABrHTERCpykYxshFWTmJZs33NgqkjFAr5dcYNHW1oEt07IFc6c14LWtSU3mckTQMB5BcESl3hGKIeMxAGYVaD2SlkDn0OyiUMoAMKK2cQheMmSk1aTNbOZaEZjiXMNYRTpKqU2h5GETXZMH7dE8swmlsAJAC3kEwjYExqoCiS4EtVBgEUs0IkEAhpNIAIMmtCFVaHl0JmBFcBQdAMYAKYzvb/LiWAF8NzdAA7dCb4+ooxfCUyeJeGWAxFA1Cksdf50PepNY/FyhIDj5ULd655ikJ8B+IALNP9YAlWzOn1zlqlt8NzUxlgAo4qwia1xnexf+xrZxeYjHFdwTEGomtvF7qW4L7dEXoP62Zu44SM0w5krN+UmcYUMvBGhbQPdmojIXne6LWfMBewypa4j9sCVCcoPuHOJL3C2s6JNZ9kggDafucoDljVlq2w7heA2ZrGNuQK0nnvhDOenFtUJAgCQ+90TFwUDoEtpRvS7QP/OX8jBPXKen9WsoEY3yiXJT4dvMIMIH/a+M+FqT5xuy2J8taJxju6C+xzTNsXpAkCQgV3uNOFCH3rxsr7OACwxBi2Xp+VWLYpEh0KaBsB2Iib98U2ns+xk//Soy7oAE7TcnTE4udjJx/f/ZLfcBS+HeSiMQvFT7LnuPx9EEws/ePcpvPKOZbsootxxUWw5xpUOO+a5evnRF1bzi4exLHSMoJyb/vSifz1AUR+KDBe4FBymkOtlv9XS816ltA9FgF1B4Art/vezjz3yLb90TpS385lI7+33c/zll9L31mdg8EXBXAQ0XhPQlW6Iqp998mG//NrbvudTswE+Y4K2QBUR+dFfvPPTX+KpkOwEvh8Jy3qI/9SnfPc3bAI4gAGgfqXQAW8VV5pAVy/RYf5WgANofwa4ds03CgVlbRpAVJJwAEeVFgqgVE8yfxV4gBJ4fwiYCgWFFwjVFh3AUPTjUAQAUS1hAbBEJyRY/4EUqIMXmH/PFE3TRE0GYE0AqHsnSH87aIAp+D2akINKeITot4RMiAlOOIFQWH5SOIWWUIUoeIXZNwCgp4WbwIVI6IXWlwCzJoZNaIbLl4QDSAFhpYa0xobI54YDKADuJ4evRoe/Z4f3BwFFqIeJQIZRyIe/JwE9KIiNQIhYaIi8l4WKuIiO+Hp+iISJGImKwIhfOImUeImbgmMk8SoQmAmaaH2VGIWeKCm2AhTKohqjUIptyImmB4mbAiyCwGiLhIevKIuYd4oDp2kB4EItFD20+IlXQRdeMU5Ox4uV54u9dmxwVAjEmIqSwhdG8RKNEYiQAIt1yIwVJnABYFLDWP9/1Bgph6QUdROHl8CNvQaMm9Z3gvd7uVREL6B2iicu5PJ/F/EAqOGKosCOhAaNF7RsSUeAy5dLL5ABouQCPHWP2QIvNIFg5TiHyweOAfB3Bbl23lhhIvdz9miBmLiOG8mRyJYBLnBw8Sh7ebd1CgkALqB3SheSWziSDdZwABADSJeSr8d3ficIIOBuMSmTlACQhAZKGUQIGemMpjiRQkmUZ5Z3JtBC/tSQJliC6ceUWsER2kgLWOOUYkZ5AZCTYGeV03gdpSEAo6gLXUmTC6eUbYiVWRFRYRgMa0mWOmmXBwiXQ5FhzSMA0MeV6riGeCk6JwABoXaYiJmYirmYjNn/mI75mJDJmBCglyoxFsKjYZrwAKaVHYFJiihgZmRJZG42mqRZmqZ5mqS5lUQBGS9RLYXgKhvQGC6hABtgEYiAAW7zRKcgNRhgNxFwSyXYOBrwl+JSI23RGCZxPaZxTfTDAalBQIRwAKUBOuMVOZ1ZCdIpANTZOG00gAmAAtemhmkxEqXhFb0JnQp2OwhgEozxZ5bzX8AzCu0JWqQjROjnAKWzmZhoGHx2AK/kNhTmOhdWPaHAOgEqOr1zZMsHO+0nlABQXo9wAI0BAYOkm8VynRE6PBUKnK83Wt7noACQYZfYPB4gAQKgT+/zYHkICQxDovxFR9z5okPHOHVBnIXz/2JzeQhXhQK/JQENIKO7A58jhKGLsKMHemoZEHjRU5/gNXQJADdyF4kQlVixYUFr9ZvKNKCY8CxVCpor1HItl1bRk6AM1mvwM31ymGHRdjsktjsJcKIEB5S7w11bSqSHwKYlZjmVdEly5D56w6GjxlLmBaKEwGXZxj4HKjoSEAECyUDVuUl2Gl+Iqj0ZdEkd9JHlE6OjpgIo8KGEuhe6iAjl1FVvqgRFpExCKgmmMqrkg0watGyYelg+2qQr5gAnYDqfWgid8RF0IVLk40ARgAIe0JHuE0JpeTKUYDsC4KsMhEErsEQqlaAo2mDTs6KCCBkzFD70FT0qAAEtEQEDIP8AQXB1FRp3qkqk2qpMK7AA7SSmAPWn21pfxpqrhpBhu8I60xpQJioAQuQAAjAE5Oqo4TqcLHqd+KpSgvBOakWjzHpcRKaf9CoIBkUI35WnoNYALdGdAYACRXBTZbdVRIamisUIFUtoo6VAJ1Y6mhSxhjCEgrBf5POkLcGjrmMEUgJ0XPWkymVPjQCzOZuoOfubQLtVj8qyhTBBE0Y+o9USKLs7LLVaD1ZUTZK0sAe1DdCmhXVf1gqideE2ZbpWJ+AStMo7AgBcFIA8EFsz91RcjeWW2nO2VtpTdGq0osqvYys6LNUSHgCkvlS2xvWdmNVdqlOymTeS30mzWeo7Ivv/qco5tL6EAt/quGQbXizVoPllCD4bWm7LQCzlnm9LWmlLt2KFqAIwtGfLtF6qPW9aX/iJq2pbCFQLtWy5OCaqsQKksjYakmxbupnqEg3LQKvbXyGUMOLBtn8ruaHVO/a5VioquqI6PEPEu8vUEp5bSsFLrS2VGNpBuPQHO1aqtc6bntjjOk0bAL3zrfnKuQ1Qq2FLF3UxvhVoqwLwNjsbvoRgS0ALAYNGOkzLh4WJZN1KvcibvAMMXAF8rPRKABKgPSeAAo2TsRarTChwaUh2AgtsYpurVoZmv3eqfCPgEvNlWP6avv2Vwcl3ZsWYwMrnrwpaWBcgABFcwtwGjEjq/2maO7tICkAOycG5gW798z8B5AEU6lgQ4AGARmyNepEadFM3HF4i0HId9JJBycODsHsl9UFvyreoKr1iRmwCFwMAEHHtpKSGlQAFzFUr55FTTMV6hW5IpERmFQEXXFiLSmgKZ5QAkFJiiXlPfFMl8E8gycY9XDx9+sFnPKZwesS4hsd6nMemJwIt4AJLBAKflsK5Wn17ejkQEAEx7D4OgKV2vMj8lMm7lAKmV0kp1U5JZ8mfeny7BMijc7Vc5aNa3GBIfHcigEwlsAB9OnqAxHIut8ZUvHvt9E7x5FMCMMfKZKIkjMGiVnjP6k6JB1AJEAISsMlByK8QIAEhcMjkw/8Cy6awwszDu4dS0pPMAGWiXytkJhxQIeAB3+oBA9DNZlzPZhwCA+ABWiMAHhACnUx6lBmJhPjCEPDPo+Ot68zOspgA8Hy1F2DQAXUBPsrP3qx9Aa2IjKgCEbC8mdoAERCvmGbC5wsBzdxLI+CtgKpWrEyommg+/EzP99zQd6vIhXU8/FzLKnW6xHR6Fy2IsOgAF+ABGOsSDeABD41ybqsCHl3RWbrRIN1TKw2iXjl6bvnCWKtd+CkACW3RgjzIg6mRW/XBylxfzKzSPa2HU92LZkgBsrxitAzQXd3GXw3WKgUBKIDGwgiT7oMCQwzVZy2Had2MXvimTG05W0TNXDz/e3+thoE9eL54zWoljh+rTNvce4stho0tdr5Yvj0lCPCUkfO0vn4d15k9dL6Y2AhLCD11vYpN2rObbqf91Mpkbjnrt8B32VpY2kjthagNULS9VaytTFHtoLrdll7I2amtVrBj2a4911WZzn2NZJU92l1d3APni4QtZtlN3YJs3bBthnYtZnwN19X92sXmjGw91v311sxd3s6tlGIdaInc3t1t3r1W1ckM0Qurzjzd3HOd1EttYU5tWMPdlPY9apWY15Zj03vrX/C802bt319diYTgAvI00iVdSictAClN3vX93lBobiiJoA0tAUetTEA90R5Q2Fcp4cnmPzb8hLOd/8cgUAJUueDvHM/zbM/2jM/6rLf+bFwFLpPlPAjCJnvCqHYUzmyOHLPWjM1B+JvczOK9NOQhuXvk5qrLJ40G2Uu0/dvCzZYspOCB/OEpNOK/J9lBN+MLUEnNBnxsqVOSN84cfHwlZ0lbrkH1uOZebuRyanli/kfJVOb2ewCQQ36XinwJuZA81c5Vbt7+tMOi25tSJtcEx3Ved+OvdwFJgLOOfn2v7aoNaeVqWGUIkBiu15OAh3xbhwRs4gJE0OUVZsb9FemSHrHpVVteTX8UAAQwclO89untOOh0nqsYIE0C5t0NRqMQfJfhRevhZXIJh9syU0JHITfKXl+wQ72y/f/cFSbswk3tF3OW1lII2X5cMju/zQzu5nfg086yuOKP5q7epre0/Jq6uyMB9K5d7F5KiBixzHUUu4W/sie/LfG7IOQ7k2rL7u5LvoPAmF2DGGXorcKmOI3gQ93gSou7mWthVN5TqeqgsLVKqEPpIMK9C+dAM4u8RYvy2Ve0IMoAEZWtCFZVxlts58uvW503FmoIN79a0K7tPZ+rW7aemDsWuo4IsWuy+8rRY6q4jLD0TfzsUE+3DFDyyM4IHS9kLp3MtRzyibD1BE6TYB+SuFURi2Dt4sdb0ItkeiPAnty8keDyKr2RMC+ULIEAaVHuhkDu0Pfzzw656l6uqgn4vef/jXNLqEZR6TWCudJUc5618Gr1AfB4WPBst8Bb9Zgg9VDNi1r6qbg4JApQCAGfPJgg9r2kbE0eUGHb7BuPnpqA+r10BEKQaoVV9lKtSBFGCO4bng3Y9iqFka6Ttxxey3f/+06f+stWAW9OtHJvtBkWdbE08oPaCQerTCaJ5ukeZO6TXKrpCNevTO1WWN5vv2lBAB0QJ4gx86KQrs16kzkZwDrPQN0qQnTDPt2+Ow5XAhAHCAGCg4SFgyoQCA8AjI2Oj5CRkpOUlZaXmJmam5ydnp+goZMHEwoCFh2MBwgIGKKWBwQCJw6GhRmPPwK7A7W2gw4nAgQHr5uxs76/ggsA/yALIAAry4bBw8XG2drb3N3e3+CiDNjhjAwGDRfUJgsLLQAzNgIeFNSCFw0GDOWU5+n2HwBUCIArg71B+PTxW8iwocOHECNqKoAAQgJqFH4AIGHxYIJEBSQ+othxWQkAMaIt8AhSpMuXMGPKnAmAgAIJygo5iBBBnT0HEhQQoFnzZk5CH6K5mEYNqFCiUKNKnUpVEoMNDUL8onDUVogGG/ZBvZr1V4KL9r6Grcq2rdu3DQtYQIH2IKEEKCyEpCqXrqEBA6jh1Qu3sOHDiDtxUEDPbgAKHhRweLu48SDAWyNPTsy5s+fEpBoEtjegwQRybkOPDoD5r2nUn2PLnk20gP+BCHULJYhgYO9h27hZrxa0uzft48iTi3ygAEK9QRQgKFjkmTkECaujT1fOvbv3bwc0COjlYIAADbA5h5/noPz59N/jy5+PCcNt3q6O2+dpID/9/wAGCMkD1CFXQAEECqjgggzSRsBQDUYo4YRuPUjhhRhm+JKFGnbo4YfdcAjiiCSWiImIJqaoookHrujiizDGKOOM37VI4404fodijjz2+NmOPgYp5FtADmnkkUQVieSSTEZkY5NQRinllFTG9mSVWGb5iZJadullJFx+KaaXYY5pZpVlnqkmlFeu6eabcMaZY5ty1ilkmnbmGSOeevapIp1+BjpiARxoYIAFuyT/qigCBmjAgW+CRsogAxwYsAujDx6o6aYPGoDALgZwIJakpMZ3wAOIIjBBB6NiwkAHE3xqwQPwlWqrZ7EooMAE/oGCQSlC1XrrsDJRSgCtkzAX7Da5bkfsszM9oKgBkRxgKTHgyWKAsNB2yw8DAigQEgYQOoKBAhb0+g0GFiigrrfwlsPBeZN0sCu3zJaSSrz8hiNLuY+cOwFEpbzb78GvSEutOY0coMAGEm2gAL4IV6zJpwYQsMHCAMRKcSPGIotBAcUcUIDBlKwysMUsg3LVpZuBW6Al0iZKraUhFSAAx5lI22rLQIOiAQKZgCsuAOQCgDMAOvOcCQIaBC01KBZE/43JvFY3YukEBEywcycaWDD12JwIAGkl/z5i6bSd6Ez225iY3fPXDC/dNAAamJLuJW7D7fckcj+9s8Y3y323qAcMw7cAfzcOSeCubgCz0obTjSoCH/ft+OZVe8MARVlTEvbmpA8d4gGrQGwJ1KRvLjM3iO6MsiM+t765xxKpbPvmDqsOkcQf796ywAS7Kzzp9p7GEClHH0/6uXuXw67xzrdu7TXZ7hx89VMri602zc7Mve3N8vrKr7p+P77zp6a66s+WvBrrKciubz+la2NKwKb8d/rpzqKynwAhQShDxU5RibJAox41wAY68IEQjKAEJ0jBClrwghjMoAY3yMEOeiLwgyAMoQhHSMISmvCEKEyhClfIwha68IUwjKEMZ0jDBwYCADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Basic glucocorticoid structure and the chemical modifications (circled) that can be introduced to increase glucocorticoid and/or mineralocorticoid activity. The rings are lettered A through D. A solid line indicates that the group lies in front of the plane of the ring (beta position); a dashed line indicates that the group lies behind the plane of the ring (alpha position). A double bond in a ring (eg, between carbons 4 and 5) is referred to as \"delta\" (in this case, \"delta-4\").",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_19_11582=[""].join("\n");
var outline_f11_19_11582=null;
var title_f11_19_11583="Contents: Screening preventive medicine";
var content_f11_19_11583=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Screening preventive medicine",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Screening preventive medicine",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cardiovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/36/585\">",
"           Antimicrobial prophylaxis for bacterial endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/12/37066\">",
"           Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/28/1482\">",
"           Cardiovascular risk of smoking and benefits of smoking cessation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/50/19240\">",
"           Clinical trials of cholesterol lowering for primary prevention of coronary heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/44/30410\">",
"           Diagnostic and prognostic implications of coronary artery calcification detected by computed tomography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/28/14793\">",
"           Exercise and fitness in the prevention of cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/35/3641\">",
"           Obesity, weight reduction, and cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/28/5576\">",
"           Overview of primary prevention of coronary heart disease and stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/58/24488\">",
"           Screening for abdominal aortic aneurysm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/35/34361\">",
"           Screening for asymptomatic carotid artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/12/20679\">",
"           Screening for asymptomatic left ventricular dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/54/34665\">",
"           Screening for cardiovascular risk with C-reactive protein",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/50/26409\">",
"           Screening for coronary heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/20/18761\">",
"           Screening for coronary heart disease in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/26/20903\">",
"           Screening for inherited thrombophilia in asymptomatic populations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/43/3767\">",
"           Screening for intracranial aneurysm",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/40/24200\">",
"           Screening for lower extremity peripheral artery disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33241\">",
"           Screening guidelines for dyslipidemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/37/31318\">",
"           Screening to prevent sudden cardiac death in athletes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/60/40906\">",
"           Secondary prevention of cardiovascular disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General screening and prevention",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/62/23529\">",
"           Aspirin in the primary prevention of cardiovascular disease and cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/46/34537\">",
"           Evidence-based approach to prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/59/15289\">",
"           Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/4/37962\">",
"           Overview of preventive medicine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/3/23609\">",
"           Overview of smoking cessation management in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/13/17626\">",
"           Pharmacotherapy for smoking cessation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/41/20120\">",
"           Primary care of gay men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/17/21785\">",
"           Radiation-related risks of imaging studies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/38/28261\">",
"           Screening for testicular cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infectious disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/36/585\">",
"           Antimicrobial prophylaxis for bacterial endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41670\">",
"           Approach to immunizations in healthy adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/0/13322\">",
"           Immunizations for healthcare providers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/21/2394\">",
"           Immunizations for travel",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/25/37273\">",
"           Immunizations in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/50/11047\">",
"           Pneumococcal immunization in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/12/21705\">",
"           Pneumococcal vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/55/3960\">",
"           Prevention of Lyme disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/3/13370\">",
"           Prevention of malaria infection in travelers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/13/8408\">",
"           Screening for Chlamydia trachomatis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/8/37002\">",
"           Seasonal influenza vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/54/7014\">",
"           Tetanus-diphtheria toxoid vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/48/8967\">",
"           Travel advice",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Metabolic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/7/26744\">",
"           Diagnosis of and screening for hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/16/2312\">",
"           Screening for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/15/12535\">",
"           Screening for hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/28/40393\">",
"           Screening for osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/32/18952\">",
"           Treatment of hereditary hemochromatosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neoplastic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39482\">",
"           Breast imaging: Mammography and ultrasonography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/24/42378\">",
"           Cancer prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/3/8248\">",
"           Cervical cancer screening tests: Evidence of effectiveness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/14/16618\">",
"           Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/31/32249\">",
"           Genetic testing for hereditary breast and ovarian cancer syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29783\">",
"           Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/0/17418\">",
"           Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/2/41001\">",
"           Measurement of prostate specific antigen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/9/3224\">",
"           Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18073\">",
"           Primary prevention of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31562\">",
"           Risk factors for prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/51/2872\">",
"           Risk prediction models for breast cancer screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16650\">",
"           Screening and early detection of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/52/6983\">",
"           Screening and prevention of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/16/38154\">",
"           Screening for cervical cancer: Rationale and recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/10/37034\">",
"           Screening for colorectal cancer: Strategies in patients at average risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/41/9881\">",
"           Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/58/28586\">",
"           Screening for lung cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/8/42122\">",
"           Screening for prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/9/38042\">",
"           Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-EA55A4E061-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f11_19_11583=[""].join("\n");
var outline_f11_19_11583=null;
